<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/217679</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Developmental Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Diversification of heart progenitor cells by EGF signaling and differential modulation of ETS protein activity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schwarz</surname>
<given-names>Benjamin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hollfelder</surname>
<given-names>Dominik</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scharf</surname>
<given-names>Katharina</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hartmann</surname>
<given-names>Leonie</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8069-5532</contrib-id>
<name>
<surname>Reim</surname>
<given-names>Ingolf</given-names>
</name>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff><institution>Friedrich-Alexander University of Erlangen-N&#x00FC;rnberg, Department of Biology, Division of Developmental Biology</institution>, Staudtstr. 5, 91058 Erlangen, <country>Germany</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>author for correspondence: Ingolf Reim, <email>ingolf.reim@fau.de</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2017</year>
</pub-date>
<elocation-id>217679</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions>
<self-uri xlink:href="217679.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>For coordinated circulation, vertebrate and invertebrate hearts require stereotyped arrangements of diverse cell populations. This study explores the process of cardiac cell diversification in the <italic>Drosophila</italic> heart, focusing on the two major cardioblast subpopulations: generic working myocardial cells and inflow valve-forming ostial cardioblasts. By screening a large collection of randomly induced mutants we identified several genes involved in cardiac patterning. Further analysis revealed an unexpected, specific requirement of EGF signaling for the specification of generic cardioblasts and a subset of pericardial cells. We demonstrate that the Tbx20 ortholog Midline acts as a direct target of the EGFR effector Pointed to repress ostial fates. Furthermore, we identified Edl/Mae, an antagonist of the ETS factor Pointed, as a novel cardiac regulator crucial for ostial cardioblast specification. Combining these findings we propose a regulatory model in which the balance between activation of Pointed and its inhibition by Edl controls cardioblast subtype-specific gene expression.</p>
</abstract>
<counts>
<page-count count="71"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The heart consists of a variety of cells with distinct molecular and physiological properties in both vertebrates and invertebrates. A complex regulatory network of transcription factors and signaling pathways orchestrates the specification of these different cell populations and their proper arrangement within a regionalized working myocardium or other functional structures such as valves, inflow and outflow tracts (reviewed in (<xref rid="c33" ref-type="bibr">Greulich, Rudat, &#x0026; Kispert, 2011</xref>; <xref rid="c64" ref-type="bibr">Miquerol &#x0026; Kelly, 2013</xref>; <xref rid="c75" ref-type="bibr">Rana, Christoffels, &#x0026; Moorman, 2013</xref>); for the invertebrate <italic>Drosophila</italic> heart see e.g. (<xref rid="c9" ref-type="bibr">Rolf Bodmer &#x0026; Frasch, 2010</xref>; <xref rid="c55" ref-type="bibr">Lehmacher, Abeln, &#x0026; Paululat, 2012</xref>; <xref rid="c60" ref-type="bibr">Lovato &#x0026; Cripps, 2016</xref>; <xref rid="c78" ref-type="bibr">Reim &#x0026; Frasch, 2010</xref>)). For example, the vertebrate T-box gene <italic>Tbx20</italic> promotes working myocardial fate by restricting <italic>Tbx2</italic> expression and enabling the expression of chamber myocardium-specific genes (<xref rid="c17" ref-type="bibr">Cai et al., 2005</xref>; <xref rid="c91" ref-type="bibr">M. K. Singh et al., 2005</xref>; <xref rid="c95" ref-type="bibr">Stennard et al., 2005</xref>). By contrast, <italic>Tbx2</italic> and <italic>Tbx3</italic> repress working myocardium-specific gene expression and chamber differentiation in the non-chamber myocardium and thus contribute to the formation of endocardial cushions and structures of the conduction system (<xref rid="c22" ref-type="bibr">Christoffels et al., 2004</xref>; <xref rid="c41" ref-type="bibr">Hoogaars et al., 2007</xref>; <xref rid="c92" ref-type="bibr">R. Singh et al., 2012</xref>). Normal endocardial cushion formation also requires COUP-TFII, an orphan nuclear receptor transcription factor that regulates cell fate decisions in several tissues (<xref rid="c56" ref-type="bibr">Lin et al., 2012</xref>; <xref rid="c106" ref-type="bibr">S. P. Wu, Yu, Tsai, &#x0026; Tsai, 2016</xref>). In the embryonic mouse myocardium, COUP-TFII is restricted to atrial cardiomyocytes, a pattern consistent with a function in promoting atrial over ventricular fate (<xref rid="c56" ref-type="bibr">Lin et al., 2012</xref>; <xref rid="c105" ref-type="bibr">S. P. Wu et al., 2013</xref>). This function appears to involve the up-regulation of <italic>Tbx5</italic> (<xref rid="c105" ref-type="bibr">S. P. Wu et al., 2013</xref>), another T-box gene with non-uniform cardiac expression and a fundamental role in heart development and human cardiac disease (<xref rid="c6" ref-type="bibr">Basson et al., 1997</xref>; <xref rid="c11" ref-type="bibr">Bruneau et al., 1999</xref>; <xref rid="c12" ref-type="bibr">Bruneau et al., 2001</xref>; <xref rid="c31" ref-type="bibr">Ghosh, Brook, &#x0026; Wilsdon, 2017</xref>; <xref rid="c93" ref-type="bibr">Steimle &#x0026; Moskowitz, 2017</xref>). Furthermore, FGF-mediated receptor tyrosine kinase (RTK) signaling upstream of the cardiogenic transcription factor Nkx2-5 was recently shown to sustain ventricular chamber identity of cardiomyocytes in zebrafish (<xref rid="c71" ref-type="bibr">Pradhan et al., 2017</xref>). As emphasized below, spatial restriction of cardiac transcription factors as well as precisely controlled RTK signaling activities are not only important in vertebrate but also invertebrate hearts ((<xref rid="c29" ref-type="bibr">Gajewski, Choi, Kim, &#x0026; Schulz, 2000</xref>; <xref rid="c58" ref-type="bibr">Lo &#x0026; Frasch, 2001</xref>; <xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>) and this work).</p>
<p>The <italic>Drosophila</italic> heart (dorsal vessel) comprises several types of cardiomyocytes (in the embryo called cardioblasts, CBs) and non-contractile pericardial cells (PCs) (<xref rid="c9" ref-type="bibr">Rolf Bodmer &#x0026; Frasch, 2010</xref>; <xref rid="c60" ref-type="bibr">Lovato &#x0026; Cripps, 2016</xref>). The progenitors of these cells are specified in segmentally repeated heart fields located at the intersection of BMP/Dpp and Wg/Wnt signaling activities (<xref rid="c26" ref-type="bibr">Frasch, 1995</xref>; <xref rid="c77" ref-type="bibr">Reim &#x0026; Frasch, 2005</xref>; <xref rid="c107" ref-type="bibr">X. Wu, Golden, &#x0026; Bodmer, 1995</xref>). Subsequent specification of the definitive cardiogenic mesoderm depends on a conserved group of transcription factors, most importantly those encoded by the <italic>Nkx2-5</italic> ortholog <italic>tinman</italic> (<italic>tin</italic>), the <italic>Gata4</italic> ortholog <italic>pannier</italic> (<italic>pnr</italic>) and the <italic>Dorsocross1-3</italic> T-box genes (three <italic>Tbx6</italic>-related paralogs that also share features with <italic>Tbx2/3/5</italic>; in the following collectively called <italic>Doc</italic>) ((<xref rid="c2" ref-type="bibr">Alvarez, Shi, Wilson, &#x0026; Skeath, 2003</xref>; <xref rid="c3" ref-type="bibr">Azpiazu &#x0026; Frasch, 1993</xref>; <xref rid="c8" ref-type="bibr">R. Bodmer, 1993</xref>; <xref rid="c30" ref-type="bibr">Gajewski, Fossett, Molkentin, &#x0026; Schulz, 1999</xref>; <xref rid="c46" ref-type="bibr">Junion et al., 2012</xref>; <xref rid="c77" ref-type="bibr">Reim &#x0026; Frasch, 2005</xref>; <xref rid="c81" ref-type="bibr">Reim, Lee, &#x0026; Frasch, 2003</xref>); reviewed in (<xref rid="c78" ref-type="bibr">Reim &#x0026; Frasch, 2010</xref>; <xref rid="c79" ref-type="bibr">Reim, Frasch, &#x0026; Schaub, 2017</xref>)).</p>
<p>While the identification of cardiogenic factors has greatly improved our understanding of early specification events, much less is known about the mechanisms that lead to the diversification of cardiac cell subpopulations. In this study, we mainly focus on the development of the two major cardioblast subpopulations: generic cardioblasts (gCBs), which make up the main portion of the contractile tube (&#x0022;working myocardium&#x0022;), and ostial cardioblasts (oCBs), which form bi-cellular valves (ostia) for hemolymph inflow. Due to Hox gene inputs, ostial progenitor specification is limited to the abdominal region ((<xref rid="c59" ref-type="bibr">Lo, Skeath, Gajewski, Schulz, &#x0026; Frasch, 2002</xref>; <xref rid="c61" ref-type="bibr">Lovato, Nguyen, Molina, &#x0026; Cripps, 2002</xref>; <xref rid="c70" ref-type="bibr">Ponzielli et al., 2002</xref>; <xref rid="c85" ref-type="bibr">Ryan, Hoshizaki, &#x0026; Cripps, 2005</xref>), reviewed in (<xref rid="c66" ref-type="bibr">Monier, Tevy, Perrin, Capovilla, &#x0026; Semeriva, 2007</xref>)). Current research suggests that each abdominal hemisegment generates at least seven distinct progenitors that give rise to six CBs (4 gCBs &#x002B; 2 oCBs) and several types of PCs (Tin<sup>&#x002B;</sup>/<underline>E</underline>ven-skipped(Eve)<sup>&#x002B;</sup> EPCs, <underline>T</underline>in<sup>&#x002B;</sup> TPCs, and <underline>O</underline>dd-skipped(Odd)<sup>&#x002B;</sup> OPCs; (<xref rid="c9" ref-type="bibr">Rolf Bodmer &#x0026; Frasch, 2010</xref>) and references therein). Whereas gCBs (a.k.a. Tin-CBs) maintain expression of <italic>tin</italic>, oCBs (a.k.a. Svp-CBs) specifically express the <italic>COUP-TFII</italic> ortholog <italic>seven-up</italic> (<italic>svp</italic>) and <italic>Doc</italic> (<xref rid="c29" ref-type="bibr">Gajewski et al., 2000</xref>; <xref rid="c58" ref-type="bibr">Lo &#x0026; Frasch, 2001</xref>; <xref rid="c103" ref-type="bibr">Ward &#x0026; Skeath, 2000</xref>; <xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>). Previous work has shown that <italic>Doc</italic> is repressed in gCBs in a <italic>tin</italic>-dependent manner (<xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>). Robust <italic>tin</italic> expression in turn depends on the <italic>Tbx20</italic> ortholog <italic>midline</italic> (<italic>mid/nmr2</italic>). The <italic>mid</italic> gene is first activated in gCB progenitors, but later, like its paralog <italic>H15/nmr1</italic>, becomes expressed in all cardioblasts (<xref rid="c65" ref-type="bibr">Miskolczi-McCallum, Scavetta, Svendsen, Soanes, &#x0026; Brook, 2005</xref>; <xref rid="c72" ref-type="bibr">Qian, Liu, &#x0026; Bodmer, 2005</xref>; <xref rid="c82" ref-type="bibr">Reim, Mohler, &#x0026; Frasch, 2005</xref>). In oCBs, <italic>svp</italic> represses <italic>tin</italic> expression thereby permitting continued <italic>Doc</italic> expression in these cells (<xref rid="c29" ref-type="bibr">Gajewski et al., 2000</xref>; <xref rid="c58" ref-type="bibr">Lo &#x0026; Frasch, 2001</xref>; <xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>). In the abdomen, gCBs and most PCs are preceded by a precursor that undergoes symmetric division, whereas oCBs and half of the OPCs are derived from common, asymmetrically dividing CB/PC progenitors (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>; <xref rid="c37" ref-type="bibr">Han &#x0026; Bodmer, 2003</xref>; <xref rid="c103" ref-type="bibr">Ward &#x0026; Skeath, 2000</xref>).</p>
<p>The process of progenitor specification in the somatic and cardiogenic mesoderm involves the antagonistic actions of RTK/Ras/MAPK and Delta/Notch signaling (<xref rid="c19" ref-type="bibr">Carmena et al., 2002</xref>; <xref rid="c34" ref-type="bibr">Grigorian, Mandal, Hakimi, Ortiz, &#x0026; Hartenstein, 2011</xref>; <xref rid="c38" ref-type="bibr">Hartenstein, Rugendorff, Tepass, &#x0026; Hartenstein, 1992</xref>). Two types of RTKs, the fibroblast growth factor (FGF) receptor Heartless (Htl) and the epidermal growth factor (EGF) receptor EGFR, act positively on progenitor selection via MAPK signaling, although they are used by different progenitors to different extents (<xref rid="c15" ref-type="bibr">Buff, Carmena, Gisselbrecht, Jimenez, &#x0026; Michelson, 1998</xref>; <xref rid="c19" ref-type="bibr">Carmena et al., 2002</xref>; <xref rid="c63" ref-type="bibr">Michelson, Gisselbrecht, Zhou, Baek, &#x0026; Buff, 1998</xref>). Htl and its FGF8-like ligands Pyramus (Pyr) and Thisbe (Ths) have a dual function as regulators of mesodermal cell migration and cell specification, with progenitors of the Eve<sup>&#x002B;</sup> lineage as the most prominent example for the latter (reviewed in (<xref rid="c4" ref-type="bibr">Bae, Trisnadi, Kadam, &#x0026; Stathopoulos, 2012</xref>; <xref rid="c67" ref-type="bibr">Muha &#x0026; M&#x00FC;ller, 2013</xref>)). The exact contribution of EGFR signaling to <italic>Drosophila</italic> heart development has been less clear until now, but it was shown that EGFR loss of function results in a severe reduction of the numbers of cardioblasts, pericardial nephrocytes, and blood progenitors (<xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>). Molecularly, the predominant EGFR ligand in the embryo, Spitz (Spi), relies on the protease Rhomboid (encoded by <italic>rho</italic>) and the chaperon Star (S) for its conversion from a membrane-bound into its active form (reviewed in (<xref rid="c89" ref-type="bibr">Shilo, 2014</xref>)). Among the most important downstream effectors of RTK/Ras/MAPK pathways are the ETS transcription factors PntP2 (encoded by <italic>pointed/pnt</italic>) and Yan/Aop (encoded by <italic>anterior open/aop</italic>). While PntP2 becomes an active transcriptional activator upon phosphorylation by MAPK, the transcriptional repressor Yan is negatively regulated by MAPK (<xref rid="c28" ref-type="bibr">Gabay et al., 1996</xref>; <xref rid="c69" ref-type="bibr">O&#x0027;Neill, Rebay, Tjian, &#x0026; Rubin, 1994</xref>). Unlike PntP2, a shorter isoform encoded by <italic>pnt</italic>, PntP1, is constitutively active but was shown to require activated MAPK for its transcriptional activation at least in some cell types (<xref rid="c13" ref-type="bibr">Brunner et al., 1994</xref>; <xref rid="c28" ref-type="bibr">Gabay et al., 1996</xref>; <xref rid="c49" ref-type="bibr">Kl&#x00E4;mbt, 1993</xref>; <xref rid="c69" ref-type="bibr">O&#x0027;Neill et al., 1994</xref>). Notably, chordate Pnt orthologs (ETS1/2) were shown to contribute to cardiac progenitor formation in the tunicate <italic>Ciona</italic> and during transdifferentiation of human dermal fibroblasts into cardiac progenitors (<xref rid="c23" ref-type="bibr">Davidson, Shi, Beh, Christiaen, &#x0026; Levine, 2006</xref>; <xref rid="c42" ref-type="bibr">Islas et al., 2012</xref>). During early <italic>Drosophila</italic> cardiogenesis, Pnt favors expression of <italic>eve</italic> over that of another homeobox gene, <italic>ladybird</italic> (<italic>lbe</italic>, expressed in mesodermal cells immediately anterior of the Eve<sup>&#x002B;</sup> cluster and later in TPCs and two of the four gCBs per hemisegment; (K. <xref rid="c43" ref-type="bibr">Jagla et al., 1997</xref>)) (<xref rid="c57" ref-type="bibr">Liu et al., 2006</xref>). In addition, Pnt promotes pericardial cell development and antagonizes CB fate, especially that of oCBs (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>).</p>
<p>Despite the progress in the understanding of cardiac progenitor specification, the mechanisms that diversify progenitors of the oCB and gCB lineages have remained elusive. We have performed an unbiased large-scale mutagenesis screen to identify genes that regulate cardiac development in <italic>Drosophila</italic> embryos and found several mutants that show CB subtype-specific defects. On this basis we discovered a novel and rather unexpected function of the EGF pathway in specifying the gCBs of the working myocardium, thus revealing an intimate link between cardioblast specification and diversification. Furthermore we identified ETS domain lacking (Edl a.k.a. Modulator of the activity of ETS, Mae) as a crucial regulator of the specification of inflow valve-forming oCBs. Edl possesses a SAM domain, which mediates binding to the SAM domain-containing ETS factors PntP2 and Yan, thereby inhibiting their activity as a transcriptional activator or repressor, respectively (<xref rid="c5" ref-type="bibr">Baker, Mille-Baker, Wainwright, Ish-Horowicz, &#x0026; Dibb, 2001</xref>; <xref rid="c73" ref-type="bibr">Qiao et al., 2006</xref>; <xref rid="c74" ref-type="bibr">Qiao et al., 2004</xref>; <xref rid="c98" ref-type="bibr">Tootle, Lee, &#x0026; Rebay, 2003</xref>; <xref rid="c102" ref-type="bibr">Vivekanand, Tootle, &#x0026; Rebay, 2004</xref>; <xref rid="c108" ref-type="bibr">Yamada, Okabe, &#x0026; Hiromi, 2003</xref>). Our data imply that Edl enables <italic>svp</italic> expression and thus oCB fate by limiting the activity of PntP2, thereby blocking subsequent activation of important downstream targets such as <italic>pntP1</italic> and <italic>mid</italic>. Collectively, our data provide the basis for an elaborated model of cardiac cell fate diversification that links MAPK signaling, Pnt activity and the cell type-specific expression patterns of key cardiac transcription factors.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Novel EMS-induced mutants reveal a specific requirement of EGF signaling for the specification of generic cardioblasts</title>
<p>In order to identify genes involved in heart and muscle development in an unbiased manner we have performed an EMS mutagenesis screen for chromosome 2 in <italic>Drosophila melanogaster</italic> embryos (<xref rid="c40" ref-type="bibr">Hollfelder, Frasch, &#x0026; Reim, 2014</xref>). Several of the isolated mutants display a partial loss or irregular alignment of cardioblasts (CBs). Such defects may potentially result from mutations in genes that regulate the specification or differentiation of all CBs or only a particular CB subtype. In the latter case, disturbances in the characteristic &#x0022;2&#x002B;4&#x0022; CB pattern of two ostial cardioblast (oCBs; Doc<sup>&#x002B;</sup>/Tin<sup>-</sup>) and four generic CBs (gCBs; Doc<sup>-</sup>/Tin<sup>&#x002B;</sup>) per hemisegment are to be expected. To analyze the cardiac pattern of mutants in more detail, we performed immunofluorescent double stainings for Doc and H15 (or alternatively Mef2) to label oCBs and all CBs, respectively. We then genetically and in part also molecularly mapped the mutations responsible for CB pattern anomalies (for details see the Materials and Methods section and <xref ref-type="table" rid="tblS1">Table S1</xref>). The class of mutants characterized by a loss of CBs contained several novel alleles of genes involved in RTK/Ras/MAPK signaling, which is consistent with the assumed role of this pathway in cardiac progenitor selection or maintenance (<xref rid="c19" ref-type="bibr">Carmena et al., 2002</xref>; <xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>). However, no specific role for the specification of a particular cardioblast subtype or diversification of gCB versus oCB progenitors had been previously attributed to RTK/Ras/MAPK signaling. Our phenotypic analysis now shows that diminished EGF/EGFR but not FGF/Htl signaling leads to a preferential reduction of gCB numbers. Embryos with partially reduced FGF/Htl signaling, i.e. mutants lacking both copies of the FGF-encoding gene <italic>pyr</italic> and one copy of its paralog <italic>ths</italic>, as well as hypomorphic <italic>htl</italic> mutants, show an about equal reduction of gCB and oCB numbers (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, for quantification see <xref ref-type="fig" rid="fig1">Figure 1M</xref>; additional examples in <xref ref-type="fig" rid="fig1">Figure 1</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1B,C</xref>). This CB reduction can be sufficiently explained by uneven spreading of the early mesoderm to Dpp-receiving areas. By contrast, several mutations mapped to EGF signaling components feature a preferential loss of gCBs. In strong <italic>Egfr</italic> mutants very few CBs can be found (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="figS1">Figure 1-figure supplement 1E</xref>). Remarkably, the overwhelming majority of the residual CBs express Doc. The few remaining Doc-negative CBs are usually located towards the anterior and thus are possibly remnants of the oCB-free anterior aorta. In <italic>spitz, rhomboid</italic> and <italic>Star</italic> loss-of-function mutants the number of Doc<sup>-</sup>/Tin<sup>&#x002B;</sup> CBs is strongly reduced while that of ostial Doc<sup>&#x002B;</sup>/Tin<sup>-</sup> CBs is nearly normal or in some cases even increased by a few cells (<xref ref-type="fig" rid="fig1">Figure 1D-G,M</xref>, <xref ref-type="fig" rid="figS1">Figure 1-figure supplement 1E,F</xref>, <xref rid="figS2" ref-type="fig">Figure 1-figure supplement 2A-C</xref>). CBs apparently do not require activity of the ostial marker gene <italic>svp</italic> to develop and survive independently of EGF, since total CB numbers are similar in <italic>Star</italic> single and <italic>Star svp</italic> double mutants (compare <xref ref-type="fig" rid="fig1">Figure 1H</xref> to 1G; quantification in <xref ref-type="fig" rid="fig1">Figure 1M</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Genetic manipulation of EGF but not FGF signaling leads to cardioblast subtype-specific heart defects.</title>
<p>Immunostaining for the cardioblast marker H15 (red) and the ostial cardioblast marker Dorsocross (anti-Doc2&#x002B;3, green). (HG: hindgut with artificial staining in the lumen). All figures depict dorsal views of stage 16 embryos with anterior to the left unless noted otherwise. (A) Wild type (<italic>WT</italic>) CB pattern with regular alternation of gCBs (red) and oCBs (yellow) in the posterior aorta and the heart proper. The anterior aorta consists entirely of Doc<sup><italic>-</italic></sup> CBs. (B) Mutant with reduced FGF activity (<italic>pyr</italic><sup><italic>S3547</italic></sup> over a deficiency, <italic>Df(2R)BSC25</italic>, that removes <italic>pyr</italic> and <italic>ths</italic>) showing a reduction of both CB types. (C) Homozygous <italic>Egfr</italic><sup><italic>S2561</italic></sup> mutant with a severe loss of CBs. Almost all remaining CBs are Doc<sup>&#x002B;</sup>. Predominant reduction of gCBs is also observed in the EGF pathway-impairing <italic>spitz</italic> group mutants <italic>spi</italic><sup><italic>S3384</italic></sup> (D), <italic>rho</italic><sup><italic>7M43</italic></sup>/<italic>rho</italic><sup><italic>L68</italic></sup> (E), <italic>S</italic><sup><italic>S4550</italic></sup> (F) and <italic>S</italic><sup><italic>B0453</italic></sup> (G, showing an extreme case in which all retained CBs except for those of the anterior aorta are Doc<sup>&#x002B;</sup>). (H) In <italic>S</italic> <sup><italic>B0453</italic></sup> <italic>svp</italic><sup><italic>AE127</italic></sup> double mutants, total CB numbers are similar to that of <italic>S</italic> single mutants, even though all CBs are Doc-negative. (I) If the apoptosis inhibitor p35 is artificially expressed in the mesoderm of <italic>S</italic> mutants a mild increase in the number of CBs can be observed. Compared to the wild type, more Doc<sup>&#x002B;</sup> CBs are present. (J) Pan-mesodermal overexpression of dominant-negative <italic>Egfr</italic> results in a phenotype similar to <italic>spitz</italic> group mutants. Expression of <italic>rho</italic> in the entire mesoderm via <italic>how<sup>24B</sup>-GAL4</italic> (K) or at later time in dorsal mesoderm cells via <italic>tinD&#x002B;tinC&#x0394;4-GAL4</italic> (L) generates supernumerary gCBs. By contrast, oCB specification is either reduced (K) or unaffected (L) in these backgrounds. (M) Quantification of Doc<sup>&#x002B;</sup> oCBs (green), Doc<sup>-</sup> gCBs (red) and total cardioblasts (grey). The column bar chart depicts average numbers with standard deviation error bars. Asterisks indicate significant differences compared to the <italic>y w</italic> control (<italic>WT</italic>) assessed by Student&#x0027;s t-test (two-tailed, type 3; &#x002A; &#x003D; p&#x003C;0.05, &#x002A;&#x002A; &#x003D; p&#x003C;0.001; n.s. &#x003D; not significant). Comparisons between other genotypes are indicated by brackets. Pie charts display the corresponding average fraction of oCBs and gCBs.</p></caption>
<graphic xlink:href="217679_fig1.tif"/>
</fig>
<p>Previous studies in EGF pathway mutants suggested that incorrectly specified mesodermal progenitors undergo apoptosis (<xref rid="c15" ref-type="bibr">Buff et al., 1998</xref>; <xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>). Using TUNEL and anti-activated caspase stainings we could not reliably detect signs of apoptosis in the Doc-labeled cardiogenic mesoderm of <italic>Star</italic> mutants, while numerous signals were observed in other tissues (<xref ref-type="fig" rid="fig1">Figure 1</xref>-<xref ref-type="fig" rid="figS3">figure supplement 3</xref> and data not shown). If the baculoviral apoptosis inhibitor p35 (<xref rid="c111" ref-type="bibr">Zhou et al., 1997</xref>) is artificially expressed in the mesoderm of <italic>S</italic> mutants the number of CBs slightly increases in comparison to <italic>S</italic> mutants without p35 (<xref ref-type="fig" rid="fig1">Figure 1I,M</xref>). Although this is consistent with a pro-survival function of EGF signaling, it does not fully account for the gCBs missing in <italic>S</italic> mutants and suggests that the presumptive gCB progenitors largely adopt other fates at reduced EGFR activity. Collectively, these phenotypes imply that EGF signaling plays a major role in the correct specification of gCBs.</p>
</sec>
<sec id="s2b">
<title>Generic CBs and a subset of Odd<sup>&#x002B;</sup> pericardial cells require spatially and temporally coordinated EGF signals</title>
<p>Because EGF signaling is involved in multiple processes during embryogenesis we next asked whether its impact on gCB specification is directly linked to signaling activity within mesoderm cells. Indeed, mesoderm-specific attenuation of the pathway by expression of a dominant-negative EGFR variant resulted in essentially the same phenotype as with the <italic>spitz</italic> group mutants (<xref ref-type="fig" rid="fig1">Figure 1J,M</xref>). Activation of the EGF pathway in mesoderm cells appears to be largely controlled by the spatially restricted expression of <italic>rho</italic> (<xref rid="c7" ref-type="bibr">Bidet, Jagla, Da Ponte, Dastugue, &#x0026; Jagla, 2003</xref>; <xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>; <xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>). In the wild type, <italic>rho</italic> expression is first seen in the Eve<sup>&#x002B;</sup> progenitor P2 (<xref rid="c15" ref-type="bibr">Buff et al., 1998</xref>; <xref rid="c18" ref-type="bibr">Carmena, Bate, &#x0026; Jimenez, 1995</xref>; <xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>) followed by expression in the adjacent CB progenitor-containing clusters C14 and C16 ((<xref rid="c7" ref-type="bibr">Bidet et al., 2003</xref>; <xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>); see also <xref ref-type="fig" rid="fig1">Figure 1</xref>-<xref ref-type="fig" rid="figS4">figure supplement 4A-D</xref>). Overexpression of <italic>rho</italic> with the pan-mesodermal <italic>how<sup>24B</sup>-GAL4</italic> driver has been previously reported to affect the number of <italic>tin</italic>-expressing pericardial cells (<xref rid="c7" ref-type="bibr">Bidet et al., 2003</xref>), but CBs and their subtypes were not unambiguously labeled in these experiments. We extended these experiments using also other drivers.</p>
<p>Consistent with a mesoderm-autonomous function, overexpression of <italic>rho</italic> in the dorsal ectoderm (via <italic>pnr<sup>MD237</sup>-GAL4</italic>) has no significant effect on CB number or pattern (<xref ref-type="fig" rid="fig1">Figure 1M</xref> and data not shown). By contrast, all mesodermal <italic>rho</italic> overexpression setups increase the gCBs:oCBs ratio in comparison to the wild type (<xref ref-type="fig" rid="fig1">Figure 1K-M</xref> and data not shown). The impact on the absolute CB numbers depends on the timing and strength of transgene expression. The later <italic>rho</italic> is activated in mesodermal cells (with following drivers according to their temporal order and progressive spatial restriction: <italic>twist-GAL4, how<sup>24B</sup>-GAL4</italic> and <italic>tinD&#x002B;tinC&#x0394;4-GAL4</italic>) the larger the total number of CBs (<xref ref-type="fig" rid="fig1">Figure 1K-M</xref> and data not shown).</p>
<p>Since half of the <italic>odd</italic>-expressing pericardial cells (OPCs) are siblings of oCBs we also analyzed PCs in EGF-related mutants by Odd/Eve double-stainings (<xref ref-type="fig" rid="fig2">Figure 2A-C</xref> and data not shown). Consistent with the results of previous studies on Eve<sup>&#x002B;</sup> progenitor derivatives (<xref rid="c15" ref-type="bibr">Buff et al., 1998</xref>; <xref rid="c19" ref-type="bibr">Carmena et al., 2002</xref>; <xref rid="c96" ref-type="bibr">Su, Fujioka, Goto, &#x0026; Bodmer, 1999</xref>), we detected EPCs in almost normal numbers in <italic>spi</italic> group mutants and in embryos with pan-mesodermal dominant-negative EGFR, whereas <italic>spi-</italic>dependent Eve<sup>&#x002B;</sup> DA1 muscles were largely absent. OPCs are strongly reduced in these loss-of-function backgrounds. Our quantification revealed that about half of the OPCs were lost in <italic>rho</italic><sup><italic>7M43/L68</italic></sup> mutants (-45&#x0025;, n=4). A converse phenotype with many extra OPCs is generated by <italic>rho</italic> overexpression with <italic>tinD&#x002B;tinC&#x0394;4-GAL4</italic> (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Notably, the number of oCB-sibling OPCs (as identified by <italic>svp-lacZ</italic> reporter analysis) is not significantly reduced in <italic>Star</italic> mutants if compared to the wild type (<xref ref-type="fig" rid="fig2">Figure 2E,F</xref>), thus implying that the EGF signaling-dependent OPCs are those derived from symmetrically dividing OPC progenitors.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>EGF signaling promotes the formation of Odd<sup>&#x002B;</sup> PCs.</title>
<p>(A-D) Odd/Eve staining to analyze pericardial cells (PCs). (A) In the wild type, each hemisegment contains four OPCs, two EPCs and one Eve<sup>&#x002B;</sup> somatic muscle DA1 (&#x002A;). (B) Amorphic <italic>rho</italic><sup><italic>7M43/L68</italic></sup> mutant with a loss of about half of all OPCs and all DA1 muscles. (C) Panmesodermal overexpression of the dominant-negative <italic>Egfr</italic> results in a phenotype similar to <italic>rho</italic> mutants. (D) Overexpression of <italic>rho</italic> in the dorsal mesoderm generates supernumerary OPCs. (E,F) Doc2&#x002B;3/&#x03B2;-galactosidase staining in wild type (E) and <italic>Star</italic> mutant embryos (F) carrying a heterozygous copy of <italic>svp<sup>AE127</sup>-lacZ</italic> and showing presence of normal numbers of oCBs (Doc<sup>&#x002B;</sup>/LacZ<sup>&#x002B;</sup>) and their OPC siblings (Doc<sup>-</sup>/LacZ<sup>&#x002B;</sup>). Bottom panels show a higher magnification and &#x03B2;-galactosidase single channel view of the upper panel. LG: lymph gland, RG: ring gland, FB: fat body.</p></caption>
<graphic xlink:href="217679_fig2.tif"/>
</fig>
<p>Altogether, these data demonstrate that EGF pathway activity is required in the mesoderm specifically for the specification of the symmetrically dividing gCB and OPCs progenitors, but is largely dispensable or even detrimental for the specification of the <italic>svp</italic>-expressing oCB/OPC progenitors.</p>
</sec>
<sec id="s2c">
<title>The SAM domain protein Edl promotes specification of ostial cardioblasts by blocking Pointed activity</title>
<p>Our EMS screen also yielded mutants in which the number of ostial cardioblasts was specifically reduced. One such complementation group consisting of three alleles was mapped to the <italic>numb</italic> gene (alleles listed <xref ref-type="table" rid="tblS1">Table S1</xref>), which is consistent with its well-known function as a Notch suppressor during asymmetric cell division in the oCB lineage (<xref rid="c29" ref-type="bibr">Gajewski et al., 2000</xref>; <xref rid="c103" ref-type="bibr">Ward &#x0026; Skeath, 2000</xref>). Preferential reduction of oCBs was also observed in the mutant line <italic>S0520</italic>. We found that its cardiac phenotype was caused by loss of the gene <italic>ETS domain lacking</italic> (<italic>edl</italic>) as part of a multi-gene deletion and named this mutant <italic>Df(2R)edl-S0520</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="table" rid="tblS2">Table S2</xref>). We identified <italic>edl</italic> as the gene responsible for the oCB losses by obtaining phenocopies with other <italic>edl</italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3A-D</xref> and data not shown). The <italic>lacZ</italic> enhancer trap insertion allele <italic>edl</italic><sup><italic>k06602</italic></sup> was used in most <italic>edl</italic> loss-of-function experiments since its cardiac phenotype is indistinguishable from that of <italic>Df(2R)edl-S0520</italic> and <italic>Df(2R)edl-L19</italic> (<xref ref-type="fig" rid="fig3">Figure 3C,D</xref> and data not shown), and we detected in this strain a small deletion that specifically destroys the <italic>edl</italic> gene (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="table" rid="tblS2">Table S2</xref>). Furthermore, we were able to rescue the cardiac phenotype of <italic>edl</italic> by introducing a genomic <italic>edl</italic> transgene ((<xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>); <xref ref-type="fig" rid="fig3">Figure 3E</xref>) and by artificially expressing <italic>edl</italic> in the dorsal mesoderm cells or in cardioblasts (<xref ref-type="fig" rid="fig3">Figure 3F,G</xref>), demonstrating that Edl is required directly within these cell types. In accordance, <italic>edl</italic> mRNA is found within the cardiogenic region during stages 10 to 11 and in CBs during stage 12 (<xref ref-type="fig" rid="fig3">Figure 3</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1A-C</xref>). Thereafter <italic>edl</italic> expression shifts to the pericardial region, where it persists until stage 15 (<xref ref-type="fig" rid="fig3">Figure 3</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1D</xref> and data not shown).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Edl is a decisive factor of ostial cardioblast specification.</title>
<p>(A) Map of the <italic>edl</italic> locus with the used alleles and deficiencies. (B-I) Doc2&#x002B;3/H15 stainings as in <xref ref-type="fig" rid="fig1">Figure 1</xref>. (B) Embryo with transheterozygous combination of <italic>Df(2R)edl-S0520</italic> (<italic>edl</italic><sup><italic>-</italic></sup>) and <italic>Df(2R)ED3636</italic> (<italic>edl</italic><sup><italic>&#x002B;</italic></sup>) showing a regular &#x0022;2&#x002B;4&#x0022; CB pattern of oCBs and gCBs. By contrast, amorphic <italic>edl</italic> mutants <italic>Df(2R)edl-S0520/Exel7157</italic> (C) and <italic>edl</italic><sup><italic>k06602</italic></sup> (D) have only few oCBs. Note the occurrence of &#x0022;1&#x002B;5&#x0022; CB patterns (bracket). (E) The regular CB pattern is restored by a genomic <italic>edl</italic><sup><italic>&#x002B;</italic></sup> transgene. A nearly normal CB pattern is observed in <italic>edl</italic> mutants upon expression of <italic>UAS-edl</italic> in the dorsal mesoderm via <italic>tinD-GAL4</italic> (F) or only in CBs or their progenitors via <italic>tinC&#x0394;4-GAL4</italic> (G). In cardioblast-specific <italic>tin</italic> mutants (carrying a rescue construct for early <italic>tin</italic> function) all CBs present become Doc<sup>&#x002B;</sup>, irrespective of whether <italic>edl</italic> is functional (H) or not (I). Observation of some H15<sup>-</sup> Doc<sup>&#x002B;</sup> CBs in (H) and (I) suggest that robust H15 expression requires normal <italic>tin</italic> function. (J) Mutually exclusive expression of Doc and Tin proteins in the wild type at late stage 15. (K) In <italic>edl</italic> mutants, Doc and Tin are co-expressed at low levels in some CBs (arrowhead).</p></caption>
<graphic xlink:href="217679_fig3.tif"/>
</fig>
<p>A distinctive feature of <italic>edl</italic> mutants is that the normal &#x0022;2&#x002B;4&#x0022; pattern of 2 Doc<sup>&#x002B;</sup> CB &#x002B; 4 Doc<sup>-</sup> CBs is often transformed into a &#x0022;1&#x002B;5&#x0022; pattern (e.g. bracket in <xref ref-type="fig" rid="fig3">Figure 3D</xref>), indicating a fate switch from ostial to generic CBs. However, Edl is not a direct activator of <italic>Doc</italic> expression because Doc is found in CBs of <italic>edl</italic> double mutants with CB-specific ablation of <italic>tin</italic> (<xref ref-type="fig" rid="fig3">Figure 3I</xref>), a phenotype reminiscent of that of CB-specific <italic>tin</italic> single mutants (<xref ref-type="fig" rid="fig3">Figure 3H</xref>; (<xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>)). This suggests that <italic>edl</italic> normally contributes to the activation of <italic>Doc</italic> in oCBs via suppression of <italic>tin</italic>. This role of <italic>edl</italic> in CB patterning is further supported by the observation of some CBs with low levels of Tin and Doc in <italic>edl</italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3K</xref>; compare to the strictly complementary distribution of Doc and Tin in the wild type, <xref ref-type="fig" rid="fig3">Figure 3J</xref>).</p>
<p>Next we analyzed Edl function by ectopic expression. Consistent with a mesoderm-autonomous function, overexpressing <italic>edl</italic> in the dorsal ectoderm via <italic>pnr<sup>MD237</sup>-GAL4</italic> has no significant effect on cardiogenesis (data not shown). By contrast, overexpression of <italic>edl</italic> in the entire mesoderm via <italic>twist-GAL4</italic> results in an increase of CB numbers (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and a decrease of OPCs (described in the next subsection). The increase in Doc<sup>&#x002B;</sup> CBs is disproportionately high. The extra Doc<sup>&#x002B;</sup> CBs in the heart proper also activate ostial cell differentiation markers such as <italic>wg</italic> (data not shown). In agreement with the proposed function of Edl as a negative regulator of PntP2 (<xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>), our overexpression phenotypes of <italic>edl</italic> are very reminiscent to that of <italic>pntP2</italic>-specific (<italic>pnt</italic><sup><italic>RR112</italic></sup> reported in (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>) and <italic>pnt</italic><sup><italic>MI03880</italic></sup> shown in <xref ref-type="fig" rid="fig4">Figure 4B</xref>) and amorphic <italic>pnt</italic> mutants (<italic>pnt</italic><sup><italic>&#x0394;88</italic></sup>, <italic>pnt</italic><sup><italic>2</italic></sup>; see <xref ref-type="fig" rid="fig4">Figure 4E,I</xref> and (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>)). Accordingly, overexpression of constitutively active PntP2<sup>VP16</sup> (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) or PntP1 (not shown) via <italic>tinD&#x002B;tinC&#x0394;4-GAL4</italic> causes a phenotype similar to that of <italic>edl</italic> loss-of-function mutants (<xref ref-type="fig" rid="fig3">Figure 3C,D</xref>). By contrast, analogous overexpression of the potential Edl target Yan/Aop leads to a loss of heart cells irrespective of their subtype. These losses may result from a more general block in cell specification and differentiation since Yan has been related to such functions in several other types of MAPK-dependent progenitors (<xref rid="c7" ref-type="bibr">Bidet et al., 2003</xref>; <xref rid="c20" ref-type="bibr">Caviglia &#x0026; Luschnig, 2013</xref>; <xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>; <xref rid="c76" ref-type="bibr">Rebay &#x0026; Rubin, 1995</xref>). If the predominant function of Edl during CB specification is the inhibition of Pnt, <italic>edl pnt</italic> double mutants should mimic <italic>pnt</italic> mutants. In principle, this is what we observed (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref>; quantifications in <xref ref-type="fig" rid="fig4">Figure 4I</xref>). By contrast, <italic>edl aop</italic> double mutants show an additive combination of <italic>aop</italic> and <italic>edl</italic> single mutant phenotypes (compare <xref ref-type="fig" rid="fig4">Figure 4H</xref> with 4G and 3D; see also quantifications in <xref ref-type="fig" rid="fig4">Figure 4I</xref>). Amorphic <italic>aop</italic> mutants display a reduction in CB number irrespective of CB subtype, which we ascribe to a permissive function during CB development that is probably linked to its well-documented role in restricting <italic>eve</italic> expression in the early dorsal mesoderm ((<xref rid="c7" ref-type="bibr">Bidet et al., 2003</xref>; <xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>; <xref rid="c57" ref-type="bibr">Liu et al., 2006</xref>; <xref rid="c104" ref-type="bibr">Webber, Zhang, Mitchell-Dick, &#x0026; Rebay, 2013</xref>)). Importantly, and in contrast to <italic>edl</italic> and <italic>pnt</italic> activity changes, manipulating <italic>aop</italic> activities does not lead to significant shifts in the oCBs:gCBs ratio (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Thus we suggest that Edl acts mainly via negative modulation of PntP2 activity during cardioblast diversification.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Edl promotes oCB fate via inhibition of PntP2.</title>
<p>(A-H) CB pattern in embryos with modified activity of <italic>edl</italic> and/or genes encoding the ETS proteins Pnt and Yan revealed by H15/Doc2&#x002B;3 stainings. (A) Pan-mesodermal <italic>edl</italic> overexpression via <italic>twist-GAL4</italic> leads to extra CBs with a disproportionately high increase in oCB numbers. This phenotype is reminiscent to that of the <italic>pnt</italic> mutants <italic>pnt</italic><sup><italic>MI03880</italic></sup> (a PntP2-specific mutant; here in trans with a <italic>pnt</italic>-deleting deficiency, B) and <italic>pnt</italic><sup><italic>&#x0394;88</italic></sup> (without any functional Pnt isoform, E). (C,C&#x0027;) Conversely, an <italic>edl</italic> mutant-like phenotype (loss/conversion of oCBs, exemplified by arrowheads for one hemisegment, and CBs with low Doc levels marked by asterisks) is generated by overexpression of a constitutively active PntP2 variant in the dorsal/cardiogenic mesoderm. C and C&#x0027; depict strong and weak phenotypes, respectively. (D) Overexpression of the constitutively active repressor Yan/Aop leads to a loss of gCBs and oCBs. (E,F) The CB phenotypes of <italic>pnt</italic> and <italic>edl pnt</italic> double mutants are very similar suggesting that <italic>edl</italic> acts mainly by blocking Pnt activity during CB specification. (G) Hemizygous <italic>aop</italic> mutant showing a moderate reduction of both CB types. (H) <italic>edl aop</italic> double mutant combining <italic>aop</italic>-like and <italic>edl</italic>-like defects. (I) Quantification of cardioblasts in various genotypes affecting Edl, Pnt or Yan/Aop activities (annotated as in <xref ref-type="fig" rid="fig1">Figure 1M</xref>).</p></caption>
<graphic xlink:href="217679_fig4.tif"/>
</fig>
</sec>
<sec id="s2d">
<title>Edl and Pnt regulate ostial fate by controlling <italic>seven-up</italic> expression</title>
<p>The population of oCBs is characterized by expression of <italic>svp</italic>. In <italic>svp</italic> mutants all oCBs are converted into Tin<sup>&#x002B;</sup>/Doc<sup>-</sup> CBs due to de-repression of <italic>tin</italic> ((<xref rid="c29" ref-type="bibr">Gajewski et al., 2000</xref>; <xref rid="c58" ref-type="bibr">Lo &#x0026; Frasch, 2001</xref>; <xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>); <xref ref-type="fig" rid="fig5">Figure 5</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1A</xref>). Therefore we tested the possibility that Edl promotes oCB fate by regulating <italic>svp</italic>. In the wild type, expression of <italic>svp</italic> is recapitulated by the enhancer trap <italic>svp</italic><sup><italic>AE127</italic></sup><italic>-lacZ</italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; <xref rid="c58" ref-type="bibr">Lo, 2001</xref> #1072). In <italic>edl</italic> mutants, <italic>svp</italic>-LacZ expression is strongly reduced in cardiac cells (<xref ref-type="fig" rid="fig5">Figure 5B,D</xref>). The reduction in numbers of both <italic>svp</italic>-LacZ<sup>&#x002B;</sup> oCBs and OPCs at late stages (<xref ref-type="fig" rid="fig5">Figure 5D</xref> cf. 5C) suggests that <italic>edl</italic> already affects the fates of their common progenitors. Consistent with a function in promoting <italic>svp</italic> expression and oCBs fates, mesodermal overexpression of <italic>edl</italic> leads to larger numbers of <italic>svp</italic>-LacZ<sup>&#x002B;</sup> cardiac cells, particularly of CBs, where <italic>svp</italic> expression correlates with expanded Doc expression (<xref ref-type="fig" rid="fig5">Figure 5E,F</xref>). As shown for <italic>Doc</italic> expression, <italic>svp</italic> expression can be suppressed by PntP2 hyperactivity (green asterisks in <xref ref-type="fig" rid="fig5">Figure 5H</xref>). These observations and further evaluation of the epistatic relations between <italic>svp</italic> and <italic>edl</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1</xref>) demonstrate that <italic>edl</italic> affects CB patterning by blocking Pnt activity upstream of <italic>svp</italic>.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Edl is required for <italic>svp</italic> expression.</title>
<p>(A) In stage 12 control embryos (lateral view) carrying one copy of <italic>svp</italic><sup><italic>AE127</italic></sup><italic>-lacZ</italic>, &#x03B2;-galactosidase is detected in oCBs (arrows) and their sibling OPCs (arrowheads) within the Mef2-labeled mesoderm. (B) Cardiac <italic>svp-</italic>LacZ expression is strongly reduced in <italic>edl</italic> mutants (<italic>Df(2R)edl-S0520/Exel7157;svp</italic><sup><italic>AE127</italic></sup><italic>-lacZ/&#x002B;</italic>). (C-E) Odd/<italic>svp</italic>-LacZ staining in stage 16 embryos. (C) In the control, each hemisegment contains two oCB-related <italic>svp</italic>-LacZ<sup><italic>&#x002B;</italic></sup> OPCs and two <italic>svp</italic>-LacZ<sup><italic>-</italic></sup> OPCs. The total number of OPCs decreases if <italic>edl</italic> is absent (<italic>Df(2R)edl-S0520/edl-L19;svp</italic><sup><italic>AE127</italic></sup><italic>-lacZ/&#x002B;</italic>) (D) or overexpressed (E), but different OPC subpopulations account for these losses: <italic>svp</italic>-LacZ<sup>&#x002B;</sup> OPCs are reduced in <italic>edl</italic> mutants, <italic>svp</italic>-LacZ<sup><italic>-</italic></sup> OPCs in <italic>edl</italic> overexpressing embryos. (E,F) Pan-mesodermal overexpression of <italic>edl</italic> leads to a drastic increase in the number of <italic>svp</italic>-LacZ<sup><italic>&#x002B;</italic></sup>/Doc<sup>&#x002B;</sup> cardioblasts (Odd<sup>-</sup>). Compare F to the control in <xref ref-type="fig" rid="fig2">Figure 2E</xref>. (G,H) Mef2/Doc/&#x03B2;-galactosidase staining in <italic>svp-lacZ/&#x002B;</italic> controls (G) and embryos overexpressing constitutively active <italic>pntP2</italic><sup><italic>VP16</italic></sup> in the dorsal mesoderm (H). Overexpression of <italic>pntP2</italic><sup><italic>VP16</italic></sup> leads to reduced levels of <italic>svp</italic> and <italic>Doc</italic> expression (examples labeled with green asterisks) as compared to normal oCBs (red asterisks).</p></caption>
<graphic xlink:href="217679_fig5.tif"/>
</fig>
</sec>
<sec id="s2e">
<title>Cardioblast subtype-specific expression of the PntP1 isoform is regulated by PntP2 and Edl</title>
<p>Proposing a gCB-specific function of Pnt, we next analyzed its cardiac expression. Boisclair Lachance et al. previously reported that the expression of a fully functional genomic <italic>pnt-GFP</italic> transgene mirrors the combined expression of all Pnt isoforms (<xref rid="c10" ref-type="bibr">Boisclair Lachance et al., 2014</xref>). The authors detected Pnt-GFP fusion protein in nearly all cells of the cardiac region, but highest levels were observed in two Yan-negative clusters per hemisegment flanking Eve<sup>&#x002B;</sup> cells. We confirmed and refined these observations showing that high levels of Pnt-GFP are present in the nuclei of gCB progenitors as identified by their position, characteristically enlarged size, presence of only low levels of Doc, and absence of <italic>svp-</italic>LacZ expression (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We attribute these high total Pnt levels largely to a gCB-specific expression of the PntP1 isoform since PntP1-specific antibodies (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>) specifically label gCB progenitors (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), whereas <italic>pntP2</italic> transcripts are present in a rather uniform pattern in the mesoderm including the cardiogenic area ((<xref rid="c49" ref-type="bibr">Kl&#x00E4;mbt, 1993</xref>) and data not shown). We further speculated that PntP2 could activate <italic>pntP1</italic> transcription in gCB progenitors for a sustained signaling response as found in other tissues (<xref rid="c90" ref-type="bibr">Shwartz, Yogev, Schejter, &#x0026; Shilo, 2013</xref>). This assumption is indeed supported by our genetic data. First, we detect PntP1 in an expanded pattern in the cardiogenic mesoderm of <italic>edl</italic> mutants in which PntP2 activity is assumed to increase (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Second, overexpression of <italic>edl</italic> (i.e. repression of PntP2 function) as well as genetic disruption of <italic>pntP2</italic> resulted in a near-complete loss of cardiac PntP1 (<xref ref-type="fig" rid="fig6">Figure 6D,E</xref>; note persistent expression of PntP1 in other cells located more laterally). We conclude that the combined activities of Edl and PntP2 lead to the confined <italic>pntP1</italic> expression in gCBs. The EGF Spitz appears to be a major, although not necessarily the sole factor for the MAPK-mediated activation of PntP2 in this context, because PntP1 levels are reduced but not eradicated in cardiac cells of amorphic <italic>spi</italic> mutants (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>PntP1 and Mid are specifically expressed in early gCB progenitors to antagonize oCB fate.</title>
<p>(A) Detection of Doc2&#x002B;3, &#x03B2;-galactosidase and GFP-tagged Pnt (all isoforms) in a <italic>pnt-GFP/&#x002B;; svp-lacZ/&#x002B;</italic> embryo at the beginning of stage 12 (lateral view). Highest levels are observed in gCB progenitors (large <italic>svp</italic>-LacZ-negative nuclei with low levels of Doc, arrowheads) and low levels in oCBs and their siblings (small <italic>svp</italic>-LacZ<sup>&#x002B;</sup> nuclei with higher Doc levels, arrows). (B) At the onset of germ band retraction, PntP1 becomes expressed in gCB progenitors (arrowheads) of wild type embryos. Cardiac cells are labeled via anti-Doc3&#x002B;2 staining. PntP1 is not detected in oCBs and their siblings (arrows). (C) In <italic>edl</italic><sup><italic>-</italic></sup> mutants cardiac PntP1 expression is generally increased and detected ectopically in some small nuclei that correspond to prospective oCBs and their siblings (arrows). (D) Pan-mesodermal overexpression of <italic>edl</italic> leads to a strong decrease of cardiac PntP1 expression while other mesodermal tissues are less affected. (E) The same effect is seen in <italic>pntP2</italic> mutants. (F) In <italic>spi</italic> mutants PntP1 levels are reduced as well, although not as severely as upon loss of <italic>pntP2</italic> function. (G) Like PntP1, Mid protein is found in gCB progenitors (arrowheads), but not in prospective oCBs (arrows) at the beginning of germ band retraction. (H,I) The cardiac phenotype of <italic>mid</italic> mutants is characterized by variable expansion of Doc, which largely correlates with ectopic <italic>svp</italic> expression in CBs (I, normal pattern shown in <xref ref-type="fig" rid="fig2">Figure 2E</xref>). (J) Overexpression of <italic>mid</italic> represses <italic>svp</italic> expression in H15-labeled cardioblasts (arrowheads indicate a hemisegment with five lacZ-negative nuclei). (K) Combining homozygous <italic>mid</italic> and <italic>edl</italic> mutations results in the restoration of oCBs in comparison to <italic>edl</italic> single mutants (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), suggesting that <italic>edl</italic> normally antagonizes <italic>mid</italic> function. An additional <italic>edl</italic> function regarding the total CB number is not rescued by abrogation of <italic>mid</italic>. (L) Overexpression of <italic>mid</italic> in the dorsal mesoderm via <italic>tinD-GAL4</italic> in a <italic>pnt</italic> null background converts many of the extra oCBs into gCBs (cf. <xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p></caption>
<graphic xlink:href="217679_fig6.tif"/>
</fig>
</sec>
<sec id="s2f">
<title>The Tbx20 ortholog Midline contributes to Pnt-dependent repression of <italic>svp</italic> in the working myocardial lineage</title>
<p>According to the common view, we expect Pnt to act as a transcriptional activator also during CB diversification, particularly since overexpression of PntP2 fused to the VP16 activator domain has essentially the same effect on cardiac patterning as PntP1 overexpression (<xref ref-type="fig" rid="fig5">Figure 5H</xref> and data not shown). Therefore, its negative impact on <italic>svp</italic> expression is likely to involve Pnt-dependent activation of a transcriptional repressor. Interestingly, the T-box factor Midline (Mid), like PntP1, shows expression in early gCB progenitors (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). We previously reported that <italic>mid</italic> functions to maintain <italic>tin</italic> expression in gCBs, thereby restricting <italic>Doc</italic> expression to oCBs (<xref rid="c85" ref-type="bibr">Reim et al., 2005</xref>). Consistent with this function our EMS screen also generated novel <italic>mid</italic> alleles showing the same CB patterning defects as previously described alleles (<xref ref-type="table" rid="tblS1">Table S1</xref>, <xref ref-type="fig" rid="fig6">Figure 6H</xref> and data not shown). While a direct regulation of <italic>tin</italic> by Mid was previously proposed to be responsible for these changes (supported by the gain- and loss-of-function phenotypes of <italic>mid</italic>; (<xref rid="c72" ref-type="bibr">Qian et al., 2005</xref>; <xref rid="c85" ref-type="bibr">Reim et al., 2005</xref>)), another non-exclusive scenario could involve repression of <italic>svp</italic> by Mid. Consistent with the latter, we observe a <italic>Doc</italic>-like expansion of <italic>svp</italic> expression in <italic>mid</italic> loss-of-function mutants (<xref ref-type="fig" rid="fig6">Figure 6I</xref>) and a reduction of <italic>svp</italic> expression upon ectopic overexpression of <italic>mid</italic> in cardiac cells (<xref ref-type="fig" rid="fig6">Figure 6J</xref>). The cardiac pattern phenotype of <italic>edl mid</italic> double mutants is a composite of the single mutant phenotypes. The number of oCBs (average oCBs: 24.4 &#x00B1;3.6; n=6) is strongly increased as compared to <italic>edl</italic> mutants, but reduced in comparison with <italic>mid</italic> mutants, with total CB numbers being similar to those of <italic>edl</italic> mutants. In some cases a near wild type pattern is observed (<xref ref-type="fig" rid="fig6">Figure 6K</xref>), although many embryos display an asymmetric arrangement of CBs. While the prevalence of many Doc-negative CBs in this background implies that <italic>mid</italic> is not the only factor that limits oCB fate, it also indicates that <italic>edl</italic> is normally required in the oCB lineage to restrict <italic>mid</italic> activity, possibly by blocking a Pnt-dependent activation of <italic>mid</italic> transcription. This hypothesis is indeed supported by the reversion of ectopic <italic>Doc</italic> and <italic>svp</italic> expression in <italic>pnt</italic> mutants upon forced <italic>mid</italic> expression (<xref ref-type="fig" rid="fig6">Figure 6L</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1C</xref>). By contrast, overexpression of the potential Mid target <italic>tin</italic> in this background only represses <italic>Doc</italic>, but not <italic>svp</italic> (<xref ref-type="fig" rid="fig6">Figure 6</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1D</xref>).</p>
<p>To further test the idea that Mid is a repressor of oCB fate downstream of <italic>pnt</italic>, we analyzed whether it is a direct target of Pnt. Notably, an enhancer identified as a Tin target and named <italic>midE19</italic> (<italic>mid180</italic> for a shorter minimal version) was recently shown to drive <italic>mid</italic> expression specifically in gCBs ((<xref rid="c45" ref-type="bibr">Jin et al., 2013</xref>; <xref rid="c86" ref-type="bibr">Ryu, Najand, &#x0026; Brook, 2011</xref>); <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Consistent with our assumption that this enhancer is also a target of Pnt, very little <italic>midE19</italic>-GFP activity is detectable in <italic>pnt</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), reduced activity is observed in embryos with mesodermal <italic>edl</italic> overexpression (<xref ref-type="fig" rid="fig7">Figure 7</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1A</xref>), and expanded activity is seen upon overexpression of PntP1 (<xref ref-type="fig" rid="fig7">Figure 7C</xref>; note occasional expansion into CBs with no detectable Tin) or PntP2<sup>VP16</sup> (not shown). An observed reduction of <italic>midE19</italic>-driven GFP levels in many of the retained Tin<sup>&#x002B;</sup> gCBs of <italic>rho</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1B</xref>) corroborates that EGF signaling feeds into <italic>mid</italic> activation. The idea that <italic>mid</italic> is a target of Pnt is further supported by the almost complete elimination of reporter activity upon mutating a single ETS binding site within the mid180 minimal cardiac enhancer (<xref ref-type="fig" rid="fig7">Figure 7D,E</xref>) as well as the strong reduction of endogenous <italic>mid</italic> transcription in emerging CBs during germ band retraction stages in <italic>pnt</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7F-I</xref>). After germ band retraction, endogenous <italic>mid</italic> is activated independent of <italic>pnt</italic> in all CBs (<xref ref-type="fig" rid="fig7">Figure 7K</xref>) as observed in the wild type (<xref ref-type="fig" rid="fig7">Figure 7J</xref>) indicating that distinct mechanisms regulate <italic>mid</italic> transcription in early gCB progenitors and maturing CBs.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Characterization of a Pnt-responsive <italic>mid</italic> enhancer.</title>
<p>(A-C) Stainings for GFP (green), H15 (red) and Tin (blue) in stage 16 embryos carrying the <italic>midE19-GFP</italic> reporter. (A) In a wild type heart, <italic>midE19</italic>-GFP is strongly expressed in the four pairs of Tin<sup>&#x002B;</sup>/H15<sup>&#x002B;</sup> gCBs (bracket), whereas no or very little GFP is detectable in Tin<sup>-</sup>/H15<sup>&#x002B;</sup> oCBs (arrows). (B) Despite an overall increase in CB number, <italic>midE19</italic>-GFP expression is severely reduced in amorphic <italic>pnt</italic> mutants. Most of the Tin<sup>&#x002B;</sup>/H15<sup>&#x002B;</sup> gCBs (purple nuclei, arrowheads) lack GFP expression. (C) Overexpression of <italic>pntP1</italic> via <italic>how</italic><sup><italic>24B</italic></sup><italic>-GAL4</italic> leads to nearly continuous <italic>midE19</italic>-GFP expression in CBs. In some instances the reporter is activated even in Tin<sup>-</sup> CBs (arrows). (D) Expression of GFP driven by the minimal cardiac <italic>mid</italic> enhancer, <italic>mid180</italic>, is less robust than <italic>midE19</italic>- GFP but shows essentially the same expression pattern. The minimal enhancer contains a single ETS binding motif flanked by two Tin binding sites (indicated in the scheme below). (E) Mutating the ETS binding site leads to near-complete abolishment of <italic>mid180</italic>-GFP expression. (F-K) Analysis of <italic>mid</italic> mRNA expression in cardiac cells doubly stained with anti-Doc3&#x002B;2 antibody. In the wild type, <italic>mid</italic> mRNA is first detected in gCB progenitors at early stage 12 (F); its expression begins to expand during germ band retraction (H) until it reaches continuous expression in all CBs at stage 13 (J). By contrast, amorphic <italic>pnt</italic> mutants show reduced cardiac <italic>mid</italic> expression during germ band retraction (G,I). Regular uniform <italic>mid</italic> expression is observed only after germ band retraction (K).</p></caption>
<graphic xlink:href="217679_fig7.tif"/>
</fig>
<p>In sum our data lead to the conclusion that EGF signaling contributes to gCB specification by at least two distinct mechanisms, Pnt-independent specification of a subset of cardiac progenitors as well as Pnt-dependent inhibition of ostial cardioblast fate. Modulation by Edl is needed to inhibit Pnt-dependent gene activation and thus enable formation of ostial cardioblasts.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>The specification and diversification of particular cell types are linked to the establishment of lineage-specific transcriptional programs. The differences in these programs are often prompted by distinct local signaling activities. The cells in the early heart fields of <italic>Drosophila</italic> acquire their cardiogenic potential by intersecting BMP and Wnt signal activities (<xref rid="c26" ref-type="bibr">Frasch, 1995</xref>; <xref rid="c77" ref-type="bibr">Reim &#x0026; Frasch, 2005</xref>; <xref rid="c107" ref-type="bibr">X. Wu et al., 1995</xref>), but cell diversification within this area requires additional regulatory inputs. Previous studies established that progenitors of cardioblasts, pericardial cells and dorsal somatic muscles are selected by RTK/Ras/MAPK signaling, whereas lateral inhibition by Delta/Notch signaling activity counteracts this selection in neighboring non-progenitor cells (<xref rid="c19" ref-type="bibr">Carmena et al., 2002</xref>; <xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>; <xref rid="c38" ref-type="bibr">Hartenstein et al., 1992</xref>). The progenitors of the definitive cardiogenic mesoderm, which give rise to all cardiac cells except for the somatic muscle lineage-related EPCs, co-express the cardiogenic factors Tin, Doc and Pnr, a unique feature that separates them from other cells (<xref rid="c77" ref-type="bibr">Reim &#x0026; Frasch, 2005</xref>). In addition to limiting the number of progenitors, Notch signaling has a second function during <italic>Drosophila</italic> cardiogenesis that promotes pericardial (or in thoracic segments, hematopoietic) over myocardial fate (<xref rid="c1" ref-type="bibr">Albrecht, Wang, Holz, Bergter, &#x0026; Paululat, 2006</xref>; <xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>; <xref rid="c38" ref-type="bibr">Hartenstein et al., 1992</xref>; <xref rid="c62" ref-type="bibr">Mandal, Banerjee, &#x0026; Hartenstein, 2004</xref>). Other factors previously reported to impose heterogeneity in the heart field include the cross-repressive activities of the homeodomain factors Eve and Lbe (<xref rid="c44" ref-type="bibr">T. Jagla, Bidet, Da Ponte, Dastugue, &#x0026; Jagla, 2002</xref>) as well as ectoderm-derived Hedgehog (Hh) signals (<xref rid="c57" ref-type="bibr">Liu et al., 2006</xref>; <xref rid="c70" ref-type="bibr">Ponzielli et al., 2002</xref>). In segmental subsets of cardioblasts, Hh signaling was proposed to act as a potential activator of <italic>svp</italic> in prospective oCBs (<xref rid="c70" ref-type="bibr">Ponzielli et al., 2002</xref>) but whether these are direct or indirect effects of Hh on these cells has not been ascertained.</p>
<p>Based on the findings of our study, we present a novel model of cardioblast diversification that introduces EGF signaling activities and lineage-specific modulation of the MAPK effector Pointed by Edl as crucial factors for the specification of generic working myocardial and ostial cell fates.</p>
<sec id="s3a">
<title>A novel model for cardioblast diversification connecting EGF signaling, ETS protein activity and lineage-specific transcription factor patterns</title>
<p>Combining previous findings with our new data we have conceived the regulatory model of cardioblast diversification illustrated in <xref ref-type="fig" rid="fig8">Figure 8</xref>. We propose that EGF/MAPK signaling promotes the development of generic working myocardial progenitors (red/left cell in <xref ref-type="fig" rid="fig8">Figure 8</xref>) by two mechanisms that differ in their requirement for the ETS protein Pnt:</p>
<p>1) EGF promotes the correct selection and specification of gCB progenitors. This is evident from our loss- and gain-of-function analysis of EGF signaling components. Notably, in most hemisegments of the analyzed EGF pathway mutants the number of gCBs is reduced by even numbers, indicating a defect prior to completion of the final mitotic division at the progenitor stage. This EGF function is obviously independent of <italic>pnt</italic>, since <italic>pnt</italic> null mutants display excessive numbers of CBs (with gCB numbers comparable to the wild type or even increased), a phenotype different from that of mutants defective in EGF pathway components upstream of Pnt ((<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>) and this study).</p>
<p>2) EGF signals affect the diversification of CB progenitors by impinging on a PntP2-dependent transcriptional cascade that eventually leads to suppression of Tin<sup>-</sup> oCB and the adoption of Tin<sup>&#x002B;</sup> gCB fates. This function is mediated by stimulating the gCB progenitor-specific expression of regulatory genes such as <italic>mid</italic> (depicted in red in <xref ref-type="fig" rid="fig8">Figure 8</xref>), which in turn will promote transcription of gCB-specific differentiation genes and/or repression of oCB-specific factors (depicted in green in <xref ref-type="fig" rid="fig8">Figure 8</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Model of regulatory interactions in generic and ostial CB progenitors.</title>
<p>Genes activated in a subtype-specific manner in gCB or oCB progenitors are colored in red and green, respectively. Larger font sizes and thicker lines indicate higher levels. Dashed lines indicate presumed regulations. In principle, MAPK can be activated in cardiac progenitors by EGF/EGFR and FGF/Htl signals. Generic cardioblast development depends on EGF-activated MAPK signaling which provides <italic>pnt</italic>-independent and <italic>pnt</italic>-dependent functions. The suppression of <italic>svp</italic> and subsequent regulation of <italic>tin</italic> and <italic>Doc</italic> is a <italic>pnt</italic>-dependent function that is in part mediated by direct activation of <italic>mid</italic> via the midE19 enhancer in presumptive gCBs. This step is likely to be supported by the gCB-specific expression of constitutive active PntP1. The gCB-specific cascade may require a higher level of MAPK activity to overcome the blockage of PntP2 by Edl. Alternatively or in addition, Edl levels might be differentially regulated in gCBs and oCBs by yet unknown mechanisms. In oCB progenitors, Edl keeps activated PntP2 below a critical threshold leading to absence or delayed onset of expression of oCB fate antagonists such as <italic>mid</italic>. This in turn permits <italic>svp</italic> activation by Hox genes and Tin derived from early stages. Presumed transcriptional activators of <italic>svp</italic> acting downstream of segmental Hh signals in oCB progenitors are not mandatory in this model, although it does not categorically exclude such contributions.</p></caption>
<graphic xlink:href="217679_fig8.tif"/>
</fig>
<sec id="s3a1">
<title>Basic features of gene regulation in the gCB lineage</title>
<p>We identified <italic>mid</italic> as a key target gene of Pnt in gCB progenitors based on its early gCB-specific expression, Pnt-dependent transcriptional regulation and its ability to repress the oCB-specific regulator gene <italic>svp</italic>. Since Svp represses <italic>tin</italic> expression (<xref rid="c29" ref-type="bibr">Gajewski et al., 2000</xref>; <xref rid="c58" ref-type="bibr">Lo &#x0026; Frasch, 2001</xref>), <italic>svp</italic> suppression provides an important part of the explanation for the previously reported positive role of Mid in maintaining <italic>tin</italic> expression in gCBs (<xref rid="c72" ref-type="bibr">Qian et al., 2005</xref>; <xref rid="c85" ref-type="bibr">Reim et al., 2005</xref>), although it does not exclude the possibility that Mid stimulates <italic>tin</italic> expression also directly. Of note, the vertebrate Mid ortholog Tbx20 is also a promoter of working myocardial fate that can act as transcriptional activator and repressor depending on context (<xref rid="c17" ref-type="bibr">Cai et al., 2005</xref>; <xref rid="c91" ref-type="bibr">M. K. Singh et al., 2005</xref>; <xref rid="c94" ref-type="bibr">Stennard et al., 2003</xref>; <xref rid="c95" ref-type="bibr">Stennard et al., 2005</xref>; <xref rid="c97" ref-type="bibr">Takeuchi et al., 2005</xref>). While Tin acts as a repressor of <italic>Doc</italic> via unknown mechanisms in gCBs, it does not repress <italic>svp</italic> ((<xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>) and <xref ref-type="fig" rid="fig6">Figure 6</xref>-<xref ref-type="fig" rid="figS1">figure supplement 1D</xref>). On the contrary, at least in the early cardiogenic mesoderm, it acts as an activator of <italic>svp</italic> in oCB progenitors (<xref rid="c84" ref-type="bibr">Ryan, Hendren, Helander, &#x0026; Cripps, 2007</xref>). Thus, in the absence of appropriate repressors such as Mid, <italic>svp</italic> expression can expand into gCBs.</p>
</sec>
<sec id="s3a2">
<title>Basic features of gene regulation in the oCB lineage</title>
<p>In prospective oCB progenitors, Pnt activity must be kept in check to permit <italic>svp</italic> expression and thereby <italic>tin</italic> repression and <italic>Doc</italic> activity. Fittingly, we identified <italic>edl</italic>, a gene linked to negative regulation of MAPK signaling and cell identity determination in several tissues - including the eye (<xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>) and recently in certain somatic muscle progenitors (<xref rid="c25" ref-type="bibr">Dubois, Frendo, Chanut-Delalande, Crozatier, &#x0026; Vincent, 2016</xref>) - as a novel regulator in the context of cardiac cell specification, particularly that of oCB progenitor fate (green/right cell in <xref ref-type="fig" rid="fig8">Figure 8</xref>). This function was first hinted at by the over-proportional increase of <italic>svp</italic>-expressing oCBs in <italic>pnt</italic> mutants (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>). Our phenotypic analysis demonstrates that Edl is required for <italic>svp</italic> and <italic>Doc</italic> gene activity (the latter being due to restriction of <italic>tin</italic> expression) as well as the restriction of PntP2-dependent PntP1 expression in cardiac progenitors. Molecularly, Edl can modulate the activities of PntP2 as well as Yan (<xref rid="c5" ref-type="bibr">Baker et al., 2001</xref>; <xref rid="c73" ref-type="bibr">Qiao et al., 2006</xref>; <xref rid="c74" ref-type="bibr">Qiao et al., 2004</xref>; <xref rid="c98" ref-type="bibr">Tootle et al., 2003</xref>; <xref rid="c102" ref-type="bibr">Vivekanand et al., 2004</xref>; <xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>). The comparison of single and double mutant phenotypes, combined with the reproducibility of nearly all aspects of the cardiac <italic>pnt</italic> phenotype by Edl overexpression, implies that Edl acts primarily by inhibiting Pnt during cardiac cell diversification, although we cannot fully exclude additional interactions with Yan. Our observations further support the function of Edl as an antagonist of Pnt (first demonstrated in the context of eye and chordotonal organ development, (<xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>)) and rule out an initially proposed Pnt-stimulating function (<xref rid="c5" ref-type="bibr">Baker et al., 2001</xref>).</p>
</sec>
<sec id="s3a3">
<title>Linkage of MAPK and Pnt activities</title>
<p>The involvement of Edl also leads to important conclusions regarding the placement of Pnt function within the cardiac gene regulatory network. Based on the phenotypic discrepancies between <italic>pnt</italic> and other EGF pathway components (gain and loss of CBs, respectively), Alvarez et al. proposed that PntP2 acts independent of MAPK signaling to limit the number of CBs (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>). Since we found that Edl blocks Pnt activity in oCB progenitors, and Edl is thought to antagonize PntP2 mainly by blocking MAPK-dependent phosphorylation (<xref rid="c73" ref-type="bibr">Qiao et al., 2006</xref>), we propose that PntP2 acts downstream of MAPK also during cardiogenesis (see <xref ref-type="fig" rid="fig8">Figure 8</xref>). This is further supported by our data demonstrating <italic>spi</italic>-sensitive cardiac expression of PntP1 and the observation that, if timed properly, both EGF and Pnt activities can lead to expanded gCB and reduced oCBs populations. However, not all MAPK activities require <italic>pnt</italic>, which is the case for the pro-cardiogenic activities of EGF. Notably, parallel <italic>pnt</italic>-dependent and <italic>pnt</italic>-independent MAPK signaling functions take place also during other processes such as epithelial branching morphogenesis (<xref rid="c16" ref-type="bibr">Cabernard &#x0026; Affolter, 2005</xref>).</p>
</sec>
</sec>
<sec id="s3b">
<title>EGF signaling and cardiac progenitor selection</title>
<p>As discussed above, cardioblast formation as such is independent of <italic>pnt</italic>. How could this be achieved? Growth factor-activated MAPK can also phosphorylate the repressor Yan thereby diminishing its activity as an antagonist of progenitor selection (<xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>; <xref rid="c69" ref-type="bibr">O&#x0027;Neill et al., 1994</xref>; <xref rid="c76" ref-type="bibr">Rebay &#x0026; Rubin, 1995</xref>). Therefore, it is conceivable that MAPK activity in the context of CB progenitor selection might be primarily required to eliminate the repressive activity of Yan. This would be consistent with the observed reduction of cardiac cells upon <italic>aop/yan</italic> hyperactivation ((<xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>) and this study). In this context, a minor function of Edl could contribute to the robustness of cardiac progenitor selection and thus total cardioblast and pericardial cell numbers by reducing the repressive Yan activity.</p>
<p>According to our data, EGF signals are the major source for MAPK activation and progenitor specification in the symmetrically dividing progenitors of gCBs and OPCs. By contrast, EGF signals are dispensable (in high doses even unfavorable) for the development of progenitors of oCBs and their sibling OPCs. Thus, EGF signaling appears to be more critical for cell fate specification of cardiac cells than for their mere survival. Our overexpression studies demonstrate that the timing of EGF signals is crucial for this function. In previous studies, earlier functions of MAPK signaling might have obscured its specific impact on gCBs and OPC subtypes. While early pan-mesodermal activation of MAPK signaling or expression of constitutive active Pnt forms via the <italic>twi-GAL4</italic> driver reduces the numbers of all cardiac cells except the Eve<sup>&#x002B;</sup> progenitors ((<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>; <xref rid="c7" ref-type="bibr">Bidet et al., 2003</xref>; <xref rid="c57" ref-type="bibr">Liu et al., 2006</xref>) and our own data), later MAPK activation favors formation of the symmetrically dividing OPC and gCB progenitor subpopulations (based on our experiments with <italic>tinD-GAL4-</italic>driven <italic>rho</italic>; increased total numbers of OPCs and CBs were also observed after expressing activated forms of Ras or the receptors of FGF and EGF with a <italic>Mef2-GAL4</italic> driver, (<xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>)). We propose that the specification of these progenitors requires the context of the definitive cardiogenic mesoderm, whereas premature MAPK activation in all mesoderm cells negates any pro-cardiogenic effects due to the massive expansion of Eve<sup>&#x002B;</sup> clusters (which are normally the first cells in the heart field to display MAPK and <italic>rho</italic> activity) at the expense of the cardiac progenitors in the neighboring C14/C16 clusters (<xref rid="c15" ref-type="bibr">Buff et al., 1998</xref>; <xref rid="c44" ref-type="bibr">T. Jagla et al., 2002</xref>; <xref rid="c57" ref-type="bibr">Liu et al., 2006</xref>; <xref rid="c72" ref-type="bibr">Qian et al., 2005</xref>); and our own data not shown).</p>
</sec>
<sec id="s3c">
<title>Special features of Pnt-dependent regulation in working myocardial cells</title>
<p>Our model of CB diversification incorporates the observation that the PntP1 isoform is activated specifically in gCB progenitors in a PntP2-dependent and EGF-sensitive fashion. This is reminiscent of the situation in other tissues such as the developing eye where the PntP1 isoform is also activated in a MAPK/PntP2-dependent manner (<xref rid="c28" ref-type="bibr">Gabay et al., 1996</xref>; <xref rid="c69" ref-type="bibr">O&#x0027;Neill et al., 1994</xref>; <xref rid="c90" ref-type="bibr">Shwartz et al., 2013</xref>). We propose that PntP1 becomes activated at a particular threshold of MAPK/PntP2 activity. This activation marks a point of no return for CB diversification, because PntP1 cannot be inhibited via Edl. The activation of PntP1 also explains why <italic>edl</italic> overexpression with relatively late acting drivers such as <italic>tinD-GAL4</italic> (as used in the <italic>edl</italic> mutant rescue experiment) does not cause the cardiac phenotypes observed with early pan-mesodermal drivers.</p>
<p>Besides <italic>pntP1</italic> and the already discussed <italic>mid</italic> gene, there are very likely additional target genes activated by PntP2 and/or PntP1 to execute the differentiation program in generic working myocardial cells. Incomplete conversion of gCBs in <italic>mid</italic> mutants also calls for the existence of additional repressors that contribute to oCB fate suppression. Interestingly, a study investigating Tin target genes found that cardiac target enhancers of Tin are not only enriched for Tin binding sites but also for a motif highly reminiscent of ETS binding sites, termed &#x0022;cardiac enhancer enriched (CEE) motif&#x0022; (with the consensus ATT[TG]CC or GG[CA]AAT in antisense orientation) (<xref rid="c45" ref-type="bibr">Jin et al., 2013</xref>). Mutation of four CEE sites (one of which overlapping our predicted ETS binding site) in a ca. 600 bp version of the <italic>midE19</italic> enhancer nearly abolished reporter activity in that study. Thus, many of the CEE-containing Tin target enhancers might in fact also be targets of Pnt (potentially mediating ETS-dependent activation) or Yan (potentially mediating ETS-dependent repression in the absence of MAPK signals). Therefore, a combination of closely spaced Tin and ETS binding sites might be a key signature in enhancers of working myocardial genes, although additional features must be present in their architecture to distinguish them from Tin&#x002B;ETS-binding site containing enhancers active in pericardial cells or their progenitors (<xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>). The differences might include elements directly or indirectly regulated by Delta/Notch signaling. Notably, the juxtacrine Notch ligand Delta is upregulated in the CB lineage in an MAPK activity-dependent manner (<xref rid="c34" ref-type="bibr">Grigorian et al., 2011</xref>). Hence, it is conceivable that Pnt proteins might stimulate <italic>Delta</italic> transcription in gCBs to control OPC development in a non-autonomous manner. This would explain both, simultaneous mis-specification of gCB progenitors and non-ostial-related OPCs in EGF mutants as well as phenotypic similarities between <italic>pnt</italic> mutants and mutants for components of the Delta-Notch signaling pathway. However, Notch pathway mutants do not display a biased increase of oCBs ((<xref rid="c1" ref-type="bibr">Albrecht et al., 2006</xref>) and our own data not shown) because of the herein described function of Pnt in suppressing <italic>svp</italic> transcription and oCB fate.</p>
</sec>
<sec id="s3d">
<title>What is the original signal that discriminates generic and ostial progenitors?</title>
<p>Our model proposes that factors that tilt the balance between PntP2 activity and Edl will have a major impact on CB subtype choice (see <xref ref-type="fig" rid="fig8">Figure 8</xref>). Thus any input that modestly increases MAPK/PntP2 activity within the appropriate window of time would favor gCB fate, whereas factors that have the opposite effect should promote oCB specification. This points to activities that impinge on the highly complex and dynamic expression of <italic>rho</italic>, because the Rhomboid protease is a key determinant in the decision of which cells will activate the more broadly expressed EGF Spitz and thus emanate signaling activity. A candidate would be Hh, which was proposed to be an oCB-promoting factor (<xref rid="c70" ref-type="bibr">Ponzielli et al., 2002</xref>). However, its effect on MAPK and <italic>rho</italic> activity in the dorsal mesoderm was suggested to be positive rather than negative (<xref rid="c57" ref-type="bibr">Liu et al., 2006</xref>). This would refute a function favoring oCB fate. The regulation of <italic>rho</italic> and the role of <italic>hh</italic> during CB diversification await more detailed analysis in future studies.</p>
<p>Factors that regulate <italic>edl</italic> expression levels might also determine the outcome of the competition between Edl and Pnt. The <italic>edl</italic> gene was found to be positively regulated by EGF signaling, and a target of Pnt and Yan, and thus was proposed to provide a negative feedback system for EGF inputs (<xref rid="c5" ref-type="bibr">Baker et al., 2001</xref>; <xref rid="c54" ref-type="bibr">Leatherbarrow &#x0026; Halfon, 2009</xref>; <xref rid="c102" ref-type="bibr">Vivekanand et al., 2004</xref>; <xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>). Our model therefore includes regulation by Pnt as a possibility (dashed arrows in <xref ref-type="fig" rid="fig8">Figure 8</xref>). ChIP-on-chip experiments suggest that <italic>edl</italic> is also targeted by cardiogenic factors (<xref rid="c46" ref-type="bibr">Junion et al., 2012</xref>).</p>
<p>The spatio-temporal dynamics and detailed mechanisms that regulate MAPK and <italic>edl</italic> activities within the cardiogenic mesoderm remain to be investigated in future studies. Such studies may also help to understand lineage decisions in other tissues and species. Edl/Mae-relatives are also present in non-Dipteran insects (e.g. <italic>Tribolium</italic>, (<xref rid="c14" ref-type="bibr">Bucher &#x0026; Klingler, 2005</xref>)), echinoderms, and the chordate <italic>Ciona</italic>. Although no clear ortholog of Edl appears to be present in vertebrates, a SAM domain-only isoform of the human Yan-relative TEL2 as well as <italic>Drosophila</italic> Edl were shown to inhibit transcriptional stimulation by the mammalian Pnt orthologs ETS1/ETS2 in cell culture (<xref rid="c35" ref-type="bibr">Gu et al., 2001</xref>; <xref rid="c101" ref-type="bibr">Vivekanand &#x0026; Rebay, 2012</xref>). Hence, the restriction of ETS protein activities by protein-protein interactions offers an intriguing mechanism to fine-tune MAPK signaling output in developing tissues of both invertebrates and vertebrates.</p>
</sec>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<sec id="s4a">
<title><italic>Drosophila melanogaster</italic> stocks</title>
<p>The mutants <italic>Df(2R)edl-S0520, Egfr</italic><sup><italic>S0167</italic></sup>, <italic>Egfr</italic><sup><italic>S2145</italic></sup>, <italic>Egfr</italic><sup><italic>S2307</italic></sup>, <italic>Egfr</italic><sup><italic>S2561</italic></sup>, <italic>mid</italic><sup><italic>S0021</italic></sup>, <italic>mid</italic><sup><italic>S2961</italic></sup>, <italic>numb</italic><sup><italic>S1342</italic></sup>, <italic>numb</italic><sup><italic>S3992</italic></sup>, <italic>numb</italic><sup><italic>S4439</italic></sup>, <italic>pyr</italic><sup><italic>S3547</italic></sup> (<xref rid="c80" ref-type="bibr">Reim, Hollfelder, Ismat, &#x0026; Frasch, 2012</xref>), <italic>spi</italic><sup><italic>S3384</italic></sup>, <italic>Star</italic><sup><italic>S4550</italic></sup> were recovered from our EMS screen. The lines <italic>mid<sup>1</sup>, UAS-mid-B2, how<sup>24B</sup>-GAL4, pnr<sup>MD237</sup>-GAL4, svp<sup>AE127</sup>-lacZ</italic> (a <italic>svp</italic> mutant in homozygous condition), <italic>UAS-svp.I, 2xPE-twi-GAL4, twi-SG24-GAL4, tinD-GAL4, UAS-tin#2, {tin-ABD}T003-1B1; tin<sup>EC40</sup>, UAS-p35</italic> were as described previously (<xref rid="c80" ref-type="bibr">Reim et al., 2012</xref>; <xref rid="c82" ref-type="bibr">Reim et al., 2005</xref>; <xref rid="c110" ref-type="bibr">Zaffran et al., 2006</xref>). In addition the following strains were used: <italic>aop</italic><sup><italic>1</italic></sup><italic>&#x003D;aop</italic><sup><italic>IP</italic></sup> (<xref rid="c68" ref-type="bibr">N&#x00FC;sslein-Volhard, Wieschaus, &#x0026; Kluding, 1984</xref>; <xref rid="c83" ref-type="bibr">Rogge et al., 1995</xref>), <italic>UAS-aop.ACT-IIa</italic> (<xref rid="c76" ref-type="bibr">Rebay &#x0026; Rubin, 1995</xref>), <italic>edl<sup>L19</sup>&#x003D;Df(2R)edl-L19</italic> (<italic>edl</italic> and some neighboring genes deleted) and <italic>UAS-edl-X</italic> (both from Y. Hiromi, (<xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>)), <italic>P{lacW}edl</italic><sup><italic>k06602</italic></sup> (<xref rid="c5" ref-type="bibr">Baker et al., 2001</xref>; <xref rid="c99" ref-type="bibr">T&#x00F6;r&#x00F6;k, Tick, Alvarado, &#x0026; Kiss, 1993</xref>), <italic>UAS-Egfr<sup>DN</sup>.B-29-77-1;UAS-Egfr<sup>DN</sup>.B-29-8-1</italic> (<xref rid="c15" ref-type="bibr">Buff et al., 1998</xref>), <italic>htl</italic><sup><italic>YY262</italic></sup> (<xref rid="c32" ref-type="bibr">Gisselbrecht, Skeath, Doe, &#x0026; Michelson, 1996</xref>), <italic>midE19-GFP</italic> ((<xref rid="c45" ref-type="bibr">Jin et al., 2013</xref>); from M. Frasch), <italic>pnt</italic><sup><italic>&#x0394;88</italic></sup> (<xref rid="c88" ref-type="bibr">Scholz, Deatrick, Klaes, &#x0026; Kl&#x00E4;mbt, 1993</xref>), <italic>pnt</italic><sup><italic>MI03880</italic></sup> (PntP2-specific; harbors a gene-trap cassette with an artificial splice acceptor followed by stop codons upstream of the <italic>pntP1</italic> transcription start site, (<xref rid="c100" ref-type="bibr">Venken et al., 2011</xref>)), <italic>UAS-pntP2<sup>VP16</sup>-2</italic> ((<xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>); originally from C. Kl&#x00E4;mbt), <italic>UAS-pntP1-3</italic> and <italic>UAS-pntP2-2</italic> (<xref rid="c48" ref-type="bibr">Klaes, Menne, Stollewerk, Scholz, &#x0026; Kl&#x00E4;mbt, 1994</xref>), <italic>PBac{pnt-GFP.FPTB}VK00037</italic> (R. Spokony and K. White, (<xref rid="c10" ref-type="bibr">Boisclair Lachance et al., 2014</xref>)), <italic>pyr</italic><sup><italic>18</italic></sup> and <italic>ths</italic><sup><italic>759</italic></sup> (<xref rid="c50" ref-type="bibr">Klingseisen, Clark, Gryzik, &#x0026; M&#x00FC;ller, 2009</xref>), <italic>rho</italic><sup><italic>7M43</italic></sup> (<xref rid="c47" ref-type="bibr">J&#x00FC;rgens, Wieschaus, N&#x00FC;sslein-Volhard, &#x0026; Kluding, 1984</xref>), <italic>rho</italic><sup><italic>L68</italic></sup> (<xref rid="c87" ref-type="bibr">Salzberg et al., 1994</xref>), <italic>rho</italic><sup><italic>EP3704</italic></sup> (<xref rid="c7" ref-type="bibr">Bidet et al., 2003</xref>), <italic>UAS-rho(ve.dC)</italic> (<xref rid="c24" ref-type="bibr">de Celis, Bray, &#x0026; Garcia-Bellido, 1997</xref>), <italic>spi</italic><sup><italic>1</italic></sup>&#x003D;<italic>spi</italic><sup><italic>IIA14</italic></sup> (<xref rid="c68" ref-type="bibr">N&#x00FC;sslein-Volhard et al., 1984</xref>), <italic>Star</italic><sup><italic>B0453</italic></sup> ((<xref rid="c21" ref-type="bibr">Chen et al., 2008</xref>), from F. Schnorrer), <italic>tinC&#x0394;4-GAL4</italic> ((<xref rid="c58" ref-type="bibr">Lo &#x0026; Frasch, 2001</xref>), from M. Frasch), <italic>Df(2R)Exel7157</italic>, and about 180 additional deficiencies spanning chromosome 2 (except where noted, all stocks available from the Bloomington Stock Center).</p>
<p>Flies expressing <italic>edl</italic><sup><italic>&#x002B;</italic></sup> from a transgene were generated anew by standard P-element transgenesis using the previously described rescue construct <italic>edl[&#x002B;t18]</italic> ((<xref rid="c108" ref-type="bibr">Yamada et al., 2003</xref>), provided by Y. Hiromi).</p>
<p>Unless noted otherwise, <italic>y w</italic> or <italic>S-18a-13b-16c.1</italic> control (<xref rid="c40" ref-type="bibr">Hollfelder et al., 2014</xref>) flies were used as wild type controls. Mutant lines were maintained over <italic>GFP-</italic> or <italic>lacZ-</italic>containing balancer chromosomes to allow recognition of homozygous embryos. Flies were raised at 25&#x00B0;C, except for UAS/GAL4-driven overexpression at 29&#x00B0;C.</p>
</sec>
<sec id="s4b">
<title>Isolation and mapping of novel EMS mutants</title>
<p>Novel EMS-induced mutants were obtained from our screen for embryonic heart and muscle defects and mapped to a particular gene through extensive complementation testing analogous to the previously described procedure (<xref rid="c40" ref-type="bibr">Hollfelder et al., 2014</xref>). Many alleles were mapped by unbiased complementation tests with a set of chromosome 2 deficiencies and subsequent non-complementation of lethality and embryonic phenotype by previously described alleles. <italic>Df(2R)edl-S0520</italic> was mapped by non-complementation of lethality with <italic>Df(2R)Exel7157, Df(2R)edl-L19</italic> and <italic>Df(2R)ED3636</italic>, but the cardiac phenotype was only reproduced <italic>in trans</italic> with <italic>Df(2R)Exel7157, Df(2R)edl-L19</italic> and <italic>edl</italic><sup><italic>k06602</italic></sup>. Novel alleles of <italic>Egfr</italic> and <italic>Star</italic> were mapped using a candidate gene approach.</p>
</sec>
<sec id="s4c">
<title>Molecular analysis of mutations and deletions</title>
<p>Several EMS alleles and the unmutagenized <italic>S-18a-13b-16c.1</italic> control were analyzed by sequencing of overlapping PCR products covering the coding sequence and splicing sites of the candidate gene as described (<xref rid="c40" ref-type="bibr">Hollfelder et al., 2014</xref>). Details about the mutations are provided in <xref ref-type="table" rid="tblS1">Table S1</xref>. The area deleted by <italic>Df(2R)edl-S0520</italic> and its approximate break points were determined by iterative PCR amplification tests. The insertion of <italic>P{lacW}edl</italic><sup><italic>k06602</italic></sup> near the <italic>edl</italic> transcription start site was confirmed by PCR using primers binding to the 5&#x0027; <italic>P</italic> end and adjacent genomic DNA. Although the integrity of the both <italic>P</italic> element ends could be confirmed by PCR, no genomic <italic>edl</italic> sequences expected next to the 3&#x0027; <italic>P</italic> end could be amplified using several primer pairs shown to amplify control DNA. This indicates that <italic>P{lacW}edl</italic><sup><italic>k06602</italic></sup> is associated with a deletion in <italic>edl</italic>. Details of the deletion mapping are listed in <xref ref-type="table" rid="tblS2">Table S2</xref>.</p>
</sec>
<sec id="s4d">
<title>Generation of reporter constructs for enhancer analysis</title>
<p>The <italic>mid180-GFP</italic> reporter constructs were generated according to a similar <italic>lacZ</italic> construct published by Ryu et al. (<xref rid="c86" ref-type="bibr">Ryu et al., 2011</xref>). The forward primer 5&#x0027;-<italic>Eco</italic>RI-CGTGCCTCCCACTTCAGGGCGG-3&#x0027; and the backward primer 5&#x0027;-<italic>Bam</italic>HI-TTAATTTCATTTTTCACTCTGCTCACTTGAGATTCCCCTGCTTTGTCTGCGGC<underline>ATT<italic><bold>TCC</bold></italic>GC</underline>TTCT-3&#x0027; were used to amply DNA from <italic>y w</italic> flies. The predicted ETS binding site matching the antisense sequence of published ETS binding motifs ((<xref rid="c36" ref-type="bibr">Halfon et al., 2000</xref>; <xref rid="c39" ref-type="bibr">Hollenhorst, McIntosh, &#x0026; Graves, 2011</xref>), underlined) was mutated by replacing the invariable <italic>TCC</italic> core (bold) with <italic>AAA</italic> in the backward primer. Amplicons were cloned into <italic>Eco</italic>RI/<italic>Bam</italic>HI of pH-Stinger-attB (<xref rid="c45" ref-type="bibr">Jin et al., 2013</xref>), sequenced and inserted into the <italic>attP2</italic> landing site via <italic>nos</italic>-driven &#x03A6;C31 integrase.</p>
</sec>
<sec id="s4f">
<title>Staining procedures</title>
<p>Embryo fixations, immunostainings for proteins and RNA in situ hybridizations were carried out essentially as described (<xref rid="c51" ref-type="bibr">Knirr, Azpiazu, &#x0026; Frasch, 1999</xref>; <xref rid="c82" ref-type="bibr">Reim &#x0026; Frasch, 2005</xref>). VectaStain Elite ABC kit (Vector Laboratories) and tyramide signal amplification (TSA, PerkinElmer Inc.) were used for detection of RNA and certain antigens (as indicated). The following antibodies were used: guinea pig anti-Doc2&#x002B;3 (1:2000, TSA) and anti-Doc3&#x002B;2 (1:1000) (<xref rid="c81" ref-type="bibr">Reim et al., 2003</xref>), rabbit anti-H15/Nmr1 (1:2000), guinea pig anti-H15/Nmr1 (1:2000), rabbit anti-Mid/Nmr1 (early stages: 1:250, TSA; late stages: 1:1000 direct) and rabbit anti-PntP1 (1:250, TSA) (all from J. Skeath; (<xref rid="c2" ref-type="bibr">Alvarez et al., 2003</xref>; <xref rid="c53" ref-type="bibr">Leal, Qian, Lacin, Bodmer, &#x0026; Skeath, 2009</xref>)), rabbit anti-Mef2 (1:1500) (from H.T. Nguyen), rat anti-Odd (1:600, TSA) (<xref rid="c52" ref-type="bibr">Kosman, Small, &#x0026; Reinitz, 1998</xref>), rabbit anti-Eve (1:3000) (<xref rid="c27" ref-type="bibr">Frasch, Hoey, Rushlow, Doyle, &#x0026; Levine, 1987</xref>), rabbit anti-Tin (1:750) (<xref rid="c109" ref-type="bibr">Yin, Xu, &#x0026; Frasch, 1997</xref>) (all from M. Frasch), rabbit anti-&#x03B2;-galactosidase (Promega, 1:1500), rabbit anti-GFP (Molecular Probes, 1:2000 and Rockland, 1:1000), mouse anti-GFP 3E6 (Life Technologies, 1:100, TSA), anti-cleaved-Caspase-3 (Asp175, Cell Signaling Technology, 1:100, TSA), sheep anti-Digoxigenin (Roche, 1:1000, TSA), monoclonal mouse antibodies anti-&#x03B2;-galactosidase 40-1a (1:20 direct or 1:50 with TSA), anti-Seven-up 5B11 (1:20, TSA) and anti-Wg 4D4 (1:30, TSA) (all from Developmental Studies Hybridoma Bank, University of Iowa), fluorescent secondary antibodies (1:200) (Jackson ImmunoResearch Laboratories and Abcam), biotinylated secondary antibodies (1:500) and HRP-conjugated anti-rabbit IgG (1:1000) (Vector Laboratories). TUNEL staining was performed as described (<xref rid="c81" ref-type="bibr">Reim et al., 2003</xref>) using the Millipore ApopTag S7100 kit in combination with TSA.</p>
<p>Digoxigenin-labeled antisense riboprobes against <italic>mid, edl, rho</italic> and <italic>pntP2</italic> were used for whole mount <italic>in situ</italic> hybridizations. The <italic>mid</italic> probe was generated as described previously (<xref rid="c82" ref-type="bibr">Reim et al., 2005</xref>). T7 promoter-tagged <italic>edl, rho</italic> and <italic>pntP2</italic> (isoform-specific exons) templates for <italic>in vitro</italic> transcription were generated by PCR (primers <italic>edl</italic>: CAATCGTGAAAGAGCGAGGGTC, T7-TGACGAGCAGAACTAAGGACTAGGC, <italic>pnt</italic>: CCAGCAGCCACCTCAATTCGGTC, T7-GCGTGCGTCTCGTTGGGGTAATTG, <italic>rho</italic>: ATGGAGAACTTAACGCAGAATGTAAACG, T7-TTAGGACACTCCCAGGTCG) from DNA of wild-type flies or flies carrying <italic>UAS-rho(ve.dC</italic>) or <italic>UAS-pntP2</italic>, respectively.</p>
<p>Embryos were mounted in Vectashield (Vector Laboratories). Images were acquired on a Leica SP5 II confocal laser scanning microscope and projected using Leica LAS-AF and ImageJ.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to Manfred Frasch for critical reading of the manuscript, Patrick Lo and Christoph Schaub for their contributions to the EMS screen, Edmar Heyland, Emi Vargatoth, Tanja Drechsler and Angela Bruns for technical assistance. We thank Manfred Frasch, Yasushi Hiromi, James Skeath, Hanh Nguyen, Frank Schnorrer, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank (University of Iowa) for providing fly stocks or reagents.</p>
</ack>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that no competing interests exist.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>BS, IR conceived, designed and performed the experiments, analyzed and interpreted the data, wrote the manuscript. DH, KS, LH performed the experiments, analyzed and interpreted the data.</p>
</sec>
<sec>
<title>Funding</title>
<p>This research was supported by grants from the Deutsche Forschungsgemeinschaft.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Albrecht</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Holz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bergter</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Paululat</surname>, <given-names>A.</given-names></string-name> (<year>2006</year>). <article-title>The ADAM metalloprotease Kuzbanian is crucial for proper heart formation in Drosophila melanogaster</article-title>. <source>Mech Dev</source>, <volume>123</volume>(<issue>5</issue>), <fpage>372</fpage>-<lpage>387</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mod.2006.03.005</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Alvarez</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>B. A.</given-names></string-name>, &#x0026; <string-name><surname>Skeath</surname>, <given-names>J. B.</given-names></string-name> (<year>2003</year>). <article-title>pannier and pointedP2 act sequentially to regulate Drosophila heart development</article-title>. <source>Development</source>, <volume>130</volume>(<issue>13</issue>), <fpage>3015</fpage>-<lpage>3026</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.00488</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Azpiazu</surname>, <given-names>N.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>1993</year>). <article-title>tinman and bagpipe: two homeo box genes that determine cell fates in the dorsal mesoderm of Drosophila</article-title>. <source>Genes Dev</source>, <volume>7</volume>(<issue>7B</issue>), <fpage>1325</fpage>-<lpage>1340</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Bae</surname>, <given-names>Y. K.</given-names></string-name>, <string-name><surname>Trisnadi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kadam</surname>, <given-names>S.</given-names></string-name>, &#x0026; <string-name><surname>Stathopoulos</surname>, <given-names>A.</given-names></string-name> (<year>2012</year>). <article-title>The role of FGF signaling in guiding coordinate movement of cell groups: guidance cue and cell adhesion regulator?</article-title> <source>Cell Adh Migr</source>, <volume>6</volume>(<issue>5</issue>), <fpage>397</fpage>-<lpage>403</lpage>. doi:10.4161/cam.21103</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Baker</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Mille-Baker</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Wainwright</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Ish-Horowicz</surname>, <given-names>D.</given-names></string-name>, &#x0026; <string-name><surname>Dibb</surname>, <given-names>N. J.</given-names></string-name> (<year>2001</year>). <article-title>Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila</article-title>. <source>Nature</source>, <volume>411</volume>(<issue>6835</issue>), <fpage>330</fpage>-<lpage>334</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35077122</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Basson</surname>, <given-names>C. T.</given-names></string-name>, <string-name><surname>Bachinsky</surname>, <given-names>D. R.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>R. C.</given-names></string-name>, <string-name><surname>Levi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Elkins</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Soults</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grayzel</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kroumpouzou</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Traill</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Leblanc-Straceski</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Renault</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Kucherlapati</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Seidman</surname>, <given-names>J. G.</given-names></string-name>, &#x0026; <string-name><surname>Seidman</surname>, <given-names>C. E.</given-names></string-name> (<year>1997</year>). <article-title>Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome</article-title>. <source>Nat Genet</source>, <volume>15</volume>(<issue>1</issue>), <fpage>30</fpage>-<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng0197-30</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Bidet</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Jagla</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Da Ponte</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Dastugue</surname>, <given-names>B.</given-names></string-name>, &#x0026; <string-name><surname>Jagla</surname>, <given-names>K.</given-names></string-name> (<year>2003</year>). <article-title>Modifiers of muscle and heart cell fate specification identified by gain-of-function screen in Drosophila</article-title>. <source>Mech Dev</source>, <volume>120</volume>(<issue>9</issue>), <fpage>991</fpage>-<lpage>1007</lpage>. doi:<pub-id pub-id-type="doi">S0925477303001825</pub-id> [pii]</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name> (<year>1993</year>). <article-title>The gene tinman is required for specification of the heart and visceral muscles in Drosophila</article-title>. <source>Development</source>, <volume>118</volume>(<issue>3</issue>), <fpage>719</fpage>-<lpage>729</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="book"><string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2010</year>). <chapter-title>Development and Aging of the Drosophila Heart</chapter-title>. In <person-group person-group-type="editor"><string-name><given-names>N.</given-names> <surname>Rosenthal</surname></string-name> &#x0026; <string-name><given-names>R. P.</given-names> <surname>Harvey</surname></string-name></person-group> (Eds.), <source>Heart Development and Regeneration</source> (Vol. <volume>1</volume>, pp. <fpage>47</fpage>-<lpage>86</lpage>): <publisher-name>Elsevier</publisher-name>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Boisclair Lachance</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Pelaez</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Cassidy</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Webber</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name>, &#x0026; <string-name><surname>Carthew</surname>, <given-names>R. W.</given-names></string-name> (<year>2014</year>). <article-title>A comparative study of Pointed and Yan expression reveals new complexity to the transcriptional networks downstream of receptor tyrosine kinase signaling</article-title>. <source>Dev Biol</source>, <volume>385</volume>(<issue>2</issue>), <fpage>263</fpage>-<lpage>278</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2013.11.002</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Bruneau</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Logan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Levi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tabin</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Seidman</surname>, <given-names>J. G.</given-names></string-name>, &#x0026; <string-name><surname>Seidman</surname>, <given-names>C. E.</given-names></string-name> (<year>1999</year>). <article-title>Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome</article-title>. <source>Dev Biol</source>, <volume>211</volume>(<issue>1</issue>), <fpage>100</fpage>-<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1006/dbio.1999.9298</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Bruneau</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Nemer</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Schmitt</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Charron</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Robitaille</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Caron</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Conner</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Gessler</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nemer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Seidman</surname>, <given-names>C. E.</given-names></string-name>, &#x0026; <string-name><surname>Seidman</surname>, <given-names>J. G.</given-names></string-name> (<year>2001</year>). <article-title>A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease</article-title>. <source>Cell</source>, <volume>106</volume>(<issue>6</issue>), <fpage>709</fpage>-<lpage>721</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Brunner</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ducker</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Oellers</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Hafen</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Scholz</surname>, <given-names>H.</given-names></string-name>, &#x0026; <string-name><surname>Kl&#x00E4;mbt</surname>, <given-names>C.</given-names></string-name> (<year>1994</year>). <article-title>The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway</article-title>. <source>Nature</source>, <volume>370</volume>(<issue>6488</issue>), <fpage>386</fpage>-<lpage>389</lpage>. doi:<pub-id pub-id-type="doi">10.1038/370386a0</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Bucher</surname>, <given-names>G.</given-names></string-name>, &#x0026; <string-name><surname>Klingler</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>Tribolium mae expression suggests roles in terminal and midline patterning and in the specification of mesoderm</article-title>. <source>Dev Genes Evol</source>, <volume>215</volume>(<issue>9</issue>), <fpage>478</fpage>-<lpage>481</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00427-005-0004-0</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Buff</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Carmena</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gisselbrecht</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jimenez</surname>, <given-names>F.</given-names></string-name>, &#x0026; <string-name><surname>Michelson</surname>, <given-names>A. M.</given-names></string-name> (<year>1998</year>). <article-title>Signalling by the Drosophila epidermal growth factor receptor is required for the specification and diversification of embryonic muscle progenitors</article-title>. <source>Development</source>, <volume>125</volume>(<issue>11</issue>), <fpage>2075</fpage>-<lpage>2086</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Cabernard</surname>, <given-names>C.</given-names></string-name>, &#x0026; <string-name><surname>Affolter</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>Distinct roles for two receptor tyrosine kinases in epithelial branching morphogenesis in Drosophila</article-title>. <source>Dev Cell</source>, <volume>9</volume>(<issue>6</issue>), <fpage>831</fpage>-<lpage>842</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.devcel.2005.10.008</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Cai</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Qyang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Rosenfeld</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>J.</given-names></string-name>, &#x0026; <string-name><surname>Evans</surname>, <given-names>S.</given-names></string-name> (<year>2005</year>). <article-title>T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis</article-title>. <source>Development</source>, <volume>132</volume>(<issue>10</issue>), <fpage>2475</fpage>-<lpage>2487</lpage>. doi:10.1242/dev.01832</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Carmena</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bate</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Jimenez</surname>, <given-names>F.</given-names></string-name> (<year>1995</year>). <article-title>Lethal of scute, a proneural gene, participates in the specification of muscle progenitors during Drosophila embryogenesis</article-title>. <source>Genes Dev</source>, <volume>9</volume>(<issue>19</issue>), <fpage>2373</fpage>-<lpage>2383</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Carmena</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Buff</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Halfon</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Gisselbrecht</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jimenez</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Baylies</surname>, <given-names>M. K.</given-names></string-name>, &#x0026; <string-name><surname>Michelson</surname>, <given-names>A. M.</given-names></string-name> (<year>2002</year>). <article-title>Reciprocal regulatory interactions between the Notch and Ras signaling pathways in the Drosophila embryonic mesoderm</article-title>. <source>Dev Biol</source>, <volume>244</volume>(<issue>2</issue>), <fpage>226</fpage>-<lpage>242</lpage>. doi:<pub-id pub-id-type="doi">10.1006/dbio.2002.0606</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Caviglia</surname>, <given-names>S.</given-names></string-name>, &#x0026; <string-name><surname>Luschnig</surname>, <given-names>S.</given-names></string-name> (<year>2013</year>). <article-title>The ETS domain transcriptional repressor Anterior open inhibits MAP kinase and Wingless signaling to couple tracheal cell fate with branch identity</article-title>. <source>Development</source>, <volume>140</volume>(<issue>6</issue>), <fpage>1240</fpage>-<lpage>1249</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.087874</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ahlford</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schnorrer</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Kalchhauser</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Fellner</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Viragh</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kiss</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Syvanen</surname>, <given-names>A. C.</given-names></string-name>, &#x0026; <string-name><surname>Dickson</surname>, <given-names>B. J.</given-names></string-name> (<year>2008</year>). <article-title>High-resolution, high-throughput SNP mapping in Drosophila melanogaster</article-title>. <source>Nat Methods</source>, <volume>5</volume>(<issue>4</issue>), <fpage>323</fpage>-<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nmeth.1191</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Christoffels</surname>, <given-names>V. M.</given-names></string-name>, <string-name><surname>Hoogaars</surname>, <given-names>W. M.</given-names></string-name>, <string-name><surname>Tessari</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Clout</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Moorman</surname>, <given-names>A. F.</given-names></string-name>, &#x0026; <string-name><surname>Campione</surname>, <given-names>M.</given-names></string-name> (<year>2004</year>). <article-title>T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers</article-title>. <source>Dev Dyn</source>, <volume>229</volume>(<issue>4</issue>), <fpage>763</fpage>-<lpage>770</lpage>. doi:<pub-id pub-id-type="doi">10.1002/dvdy.10487</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Davidson</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Beh</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Christiaen</surname>, <given-names>L.</given-names></string-name>, &#x0026; <string-name><surname>Levine</surname>, <given-names>M.</given-names></string-name> (<year>2006</year>). <article-title>FGF signaling delineates the cardiac progenitor field in the simple chordate, Ciona intestinalis</article-title>. <source>Genes Dev</source>, <volume>20</volume>(<issue>19</issue>), <fpage>2728</fpage>-<lpage>2738</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1467706</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>de Celis</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Bray</surname>, <given-names>S.</given-names></string-name>, &#x0026; <string-name><surname>Garcia-Bellido</surname>, <given-names>A.</given-names></string-name> (<year>1997</year>). <article-title>Notch signalling regulates veinlet expression and establishes boundaries between veins and interveins in the Drosophila wing</article-title>. <source>Development</source>, <volume>124</volume>(<issue>10</issue>), <fpage>1919</fpage>-<lpage>1928</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Dubois</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Frendo</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Chanut-Delalande</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Crozatier</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Vincent</surname>, <given-names>A.</given-names></string-name> (<year>2016</year>). <article-title>Genetic dissection of the Transcription Factor code controlling serial specification of muscle identities in Drosophila</article-title>. <source>Elife</source>, <volume>5</volume>. doi:<pub-id pub-id-type="doi">10.7554/eLife.14979</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>1995</year>). <article-title>Induction of visceral and cardiac mesoderm by ectodermal Dpp in the early Drosophila embryo</article-title>. <source>Nature</source>, <volume>374</volume>(<issue>6521</issue>), <fpage>464</fpage>-<lpage>467</lpage>. doi:<pub-id pub-id-type="doi">10.1038/374464a0</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hoey</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Rushlow</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Doyle</surname>, <given-names>H.</given-names></string-name>, &#x0026; <string-name><surname>Levine</surname>, <given-names>M.</given-names></string-name> (<year>1987</year>). <article-title>Characterization and localization of the even-skipped protein of Drosophila</article-title>. <source>Embo J</source>, <volume>6</volume>(<issue>3</issue>), <fpage>749</fpage>-<lpage>759</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Gabay</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Scholz</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Golembo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Klaes</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shilo</surname>, <given-names>B. Z.</given-names></string-name>, &#x0026; <string-name><surname>Kl&#x00E4;mbt</surname>, <given-names>C.</given-names></string-name> (<year>1996</year>). <article-title>EGF receptor signaling induces pointed P1 transcription and inactivates Yan protein in the Drosophila embryonic ventral ectoderm</article-title>. <source>Development</source>, <volume>122</volume>(<issue>11</issue>), <fpage>3355</fpage>-<lpage>3362</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Gajewski</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Choi</surname>, <given-names>C. Y.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>Y.</given-names></string-name>, &#x0026; <string-name><surname>Schulz</surname>, <given-names>R. A.</given-names></string-name> (<year>2000</year>). <article-title>Genetically distinct cardial cells within the Drosophila heart</article-title>. <source>Genesis</source>, <volume>28</volume>(<issue>1</issue>), <fpage>36</fpage>-<lpage>43</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Gajewski</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Fossett</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Molkentin</surname>, <given-names>J. D.</given-names></string-name>, &#x0026; <string-name><surname>Schulz</surname>, <given-names>R. A.</given-names></string-name> (<year>1999</year>). <article-title>The zinc finger proteins Pannier and GATA4 function as cardiogenic factors in Drosophila</article-title>. <source>Development</source>, <volume>126</volume>(<issue>24</issue>), <fpage>5679</fpage>-<lpage>5688</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Ghosh</surname>, <given-names>T. K.</given-names></string-name>, <string-name><surname>Brook</surname>, <given-names>J. D.</given-names></string-name>, &#x0026; <string-name><surname>Wilsdon</surname>, <given-names>A.</given-names></string-name> (<year>2017</year>). <article-title>T-Box Genes in Human Development and Disease</article-title>. <source>Curr Top Dev Biol</source>, <volume>122</volume>, <fpage>383</fpage>-<lpage>415</lpage>. doi:<pub-id pub-id-type="doi">10.1016/bs.ctdb.2016.08.006</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Gisselbrecht</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Skeath</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Doe</surname>, <given-names>C. Q.</given-names></string-name>, &#x0026; <string-name><surname>Michelson</surname>, <given-names>A. M.</given-names></string-name> (<year>1996</year>). <article-title>heartless encodes a fibroblast growth factor receptor (DFR1/DFGF-R2) involved in the directional migration of early mesodermal cells in the Drosophila embryo</article-title>. <source>Genes Dev</source>, <volume>10</volume>(<issue>23</issue>), <fpage>3003</fpage>-<lpage>3017</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Greulich</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Rudat</surname>, <given-names>C.</given-names></string-name>, &#x0026; <string-name><surname>Kispert</surname>, <given-names>A.</given-names></string-name> (<year>2011</year>). <article-title>Mechanisms of T-box gene function in the developing heart</article-title>. <source>Cardiovasc Res</source>, <volume>91</volume>(<issue>2</issue>), <fpage>212</fpage>-<lpage>222</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cvr/cvr112</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Grigorian</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mandal</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hakimi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ortiz</surname>, <given-names>I.</given-names></string-name>, &#x0026; <string-name><surname>Hartenstein</surname>, <given-names>V.</given-names></string-name> (<year>2011</year>). <article-title>The convergence of Notch and MAPK signaling specifies the blood progenitor fate in the Drosophila mesoderm</article-title>. <source>Dev Biol</source>, <volume>353</volume>(<issue>1</issue>), <fpage>105</fpage>-<lpage>118</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2011.02.024</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Gu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Shin</surname>, <given-names>B. H.</given-names></string-name>, <string-name><surname>Akbarali</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Weiss</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Boltax</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Oettgen</surname>, <given-names>P.</given-names></string-name>, &#x0026; <string-name><surname>Libermann</surname>, <given-names>T. A.</given-names></string-name> (<year>2001</year>). <article-title>Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6</article-title>. <source>J Biol Chem</source>, <volume>276</volume>(<issue>12</issue>), <fpage>9421</fpage>-<lpage>9436</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M010070200</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Halfon</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Carmena</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gisselbrecht</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sackerson</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Jimenez</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Baylies</surname>, <given-names>M. K.</given-names></string-name>, &#x0026; <string-name><surname>Michelson</surname>, <given-names>A. M.</given-names></string-name> (<year>2000</year>). <article-title>Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors</article-title>. <source>Cell</source>, <volume>103</volume>(<issue>1</issue>), <fpage>63</fpage>-<lpage>74</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Han</surname>, <given-names>Z.</given-names></string-name>, &#x0026; <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name> (<year>2003</year>). <article-title>Myogenic cells fates are antagonized by Notch only in asymmetric lineages of the Drosophila heart, with or without cell division</article-title>. <source>Development</source>, <volume>130</volume>(<issue>13</issue>), <fpage>3039</fpage>-<lpage>3051</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Hartenstein</surname>, <given-names>A. Y.</given-names></string-name>, <string-name><surname>Rugendorff</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tepass</surname>, <given-names>U.</given-names></string-name>, &#x0026; <string-name><surname>Hartenstein</surname>, <given-names>V.</given-names></string-name> (<year>1992</year>). <article-title>The function of the neurogenic genes during epithelial development in the Drosophila embryo</article-title>. <source>Development</source>, <volume>116</volume>(<issue>4</issue>), <fpage>1203</fpage>-<lpage>1220</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Hollenhorst</surname>, <given-names>P. C.</given-names></string-name>, <string-name><surname>McIntosh</surname>, <given-names>L. P.</given-names></string-name>, &#x0026; <string-name><surname>Graves</surname>, <given-names>B. J.</given-names></string-name> (<year>2011</year>). <article-title>Genomic and biochemical insights into the specificity of ETS transcription factors</article-title>. <source>Annu Rev Biochem</source>, <volume>80</volume>, <fpage>437</fpage>-<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.biochem.79.081507.103945</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Hollfelder</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name> (<year>2014</year>). <article-title>Distinct functions of the laminin beta LN domain and collagen IV during cardiac extracellular matrix formation and stabilization of alary muscle attachments revealed by EMS mutagenesis in Drosophila</article-title>. <source>BMC Dev Biol</source>, <volume>14</volume>(<issue>1</issue>), <fpage>26</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-213X-14-26</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Hoogaars</surname>, <given-names>W. M.</given-names></string-name>, <string-name><surname>Engel</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Brons</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Verkerk</surname>, <given-names>A. O.</given-names></string-name>, <string-name><surname>de Lange</surname>, <given-names>F. J.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>L. Y.</given-names></string-name>, <string-name><surname>Bakker</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Clout</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Wakker</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Barnett</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ravesloot</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Moorman</surname>, <given-names>A. F.</given-names></string-name>, <string-name><surname>Verheijck</surname>, <given-names>E. E.</given-names></string-name>, &#x0026; <string-name><surname>Christoffels</surname>, <given-names>V. M.</given-names></string-name> (<year>2007</year>). <article-title>Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria</article-title>. <source>Genes Dev</source>, <volume>21</volume>(<issue>9</issue>), <fpage>1098</fpage>-<lpage>1112</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.416007</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Islas</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Weng</surname>, <given-names>K. C.</given-names></string-name>, <string-name><surname>Robertson</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Prejusa</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Harger</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tikhomirova</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Chopra</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Iyer</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Mercola</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Oshima</surname>, <given-names>R. G.</given-names></string-name>, <string-name><surname>Willerson</surname>, <given-names>J. T.</given-names></string-name>, <string-name><surname>Potaman</surname>, <given-names>V. N.</given-names></string-name>, &#x0026; <string-name><surname>Schwartz</surname>, <given-names>R. J.</given-names></string-name> (<year>2012</year>). <article-title>Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>109</volume>(<issue>32</issue>), <fpage>13016</fpage>-<lpage>13021</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1120299109</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Jagla</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jagla</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Dretzen</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bellard</surname>, <given-names>F.</given-names></string-name>, &#x0026; <string-name><surname>Bellard</surname>, <given-names>M.</given-names></string-name> (<year>1997</year>). <article-title>ladybird, a new component of the cardiogenic pathway in Drosophila required for diversification of heart precursors</article-title>. <source>Development</source>, <volume>124</volume>(<issue>18</issue>), <fpage>3471</fpage>-<lpage>3479</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Jagla</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bidet</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Da Ponte</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Dastugue</surname>, <given-names>B.</given-names></string-name>, &#x0026; <string-name><surname>Jagla</surname>, <given-names>K.</given-names></string-name> (<year>2002</year>). <article-title>Cross-repressive interactions of identity genes are essential for proper specification of cardiac and muscular fates in Drosophila</article-title>. <source>Development</source>, <volume>129</volume>(<issue>4</issue>), <fpage>1037</fpage>-<lpage>1047</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Jin</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Stojnic</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Adryan</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Ozdemir</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Stathopoulos</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2013</year>). <article-title>Genome-wide screens for in vivo Tinman binding sites identify cardiac enhancers with diverse functional architectures</article-title>. <source>PLoS Genet</source>, <volume>9</volume>(<issue>1</issue>), <fpage>e1003195</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1003195</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Junion</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Spivakov</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Girardot</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Braun</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gustafson</surname>, <given-names>E. H.</given-names></string-name>, <string-name><surname>Birney</surname>, <given-names>E.</given-names></string-name>, &#x0026; <string-name><surname>Furlong</surname>, <given-names>E. E.</given-names></string-name> (<year>2012</year>). <article-title>A transcription factor collective defines cardiac cell fate and reflects lineage history</article-title>. <source>Cell</source>, <volume>148</volume>(<issue>3</issue>), <fpage>473</fpage>-<lpage>486</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2012.01.030</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>J&#x00FC;rgens</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Wieschaus</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>N&#x00FC;sslein-Volhard</surname>, <given-names>C.</given-names></string-name>, &#x0026; <string-name><surname>Kluding</surname>, <given-names>H.</given-names></string-name> (<year>1984</year>). <article-title>Mutations affecting the pattern of the larval cuticle inDrosophila melanogaster : II. Zygotic loci on the third chromosome</article-title>. <source>Rouxs Archives of Developmental Biology</source>, <volume>193</volume>(<issue>5</issue>), <fpage>283</fpage>-<lpage>295</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF00848157</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Klaes</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Menne</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Stollewerk</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Scholz</surname>, <given-names>H.</given-names></string-name>, &#x0026; <string-name><surname>Kl&#x00E4;mbt</surname>, <given-names>C.</given-names></string-name> (<year>1994</year>). <article-title>The Ets transcription factors encoded by the Drosophila gene pointed direct glial cell differentiation in the embryonic CNS</article-title>. <source>Cell</source>, <volume>78</volume>(<issue>1</issue>), <fpage>149</fpage>-<lpage>160</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Kl&#x00E4;mbt</surname>, <given-names>C.</given-names></string-name> (<year>1993</year>). <article-title>The Drosophila gene pointed encodes two ETS-like proteins which are involved in the development of the midline glial cells</article-title>. <source>Development</source>, <volume>117</volume>(<issue>1</issue>), <fpage>163</fpage>-<lpage>176</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Klingseisen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Clark</surname>, <given-names>I. B.</given-names></string-name>, <string-name><surname>Gryzik</surname>, <given-names>T.</given-names></string-name>, &#x0026; <string-name><surname>M&#x00FC;ller</surname>, <given-names>H. A.</given-names></string-name> (<year>2009</year>). <article-title>Differential and overlapping functions of two closely related Drosophila FGF8-like growth factors in mesoderm development</article-title>. <source>Development</source>, <volume>136</volume>(<issue>14</issue>), <fpage>2393</fpage>-<lpage>2402</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.035451</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Knirr</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Azpiazu</surname>, <given-names>N.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>1999</year>). <article-title>The role of the NK-homeobox gene slouch (S59) in somatic muscle patterning</article-title>. <source>Development</source>, <volume>126</volume>(<issue>20</issue>), <fpage>4525</fpage>-<lpage>4535</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Kosman</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Small</surname>, <given-names>S.</given-names></string-name>, &#x0026; <string-name><surname>Reinitz</surname>, <given-names>J.</given-names></string-name> (<year>1998</year>). <article-title>Rapid preparation of a panel of polyclonal antibodies to Drosophila segmentation proteins</article-title>. <source>Dev Genes Evol</source>, <volume>208</volume>(<issue>5</issue>), <fpage>290</fpage>-<lpage>294</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Leal</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Qian</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lacin</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name>, &#x0026; <string-name><surname>Skeath</surname>, <given-names>J. B.</given-names></string-name> (<year>2009</year>). <article-title>Neuromancer1 and Neuromancer2 regulate cell fate specification in the developing embryonic CNS of Drosophila melanogaster</article-title>. <source>Dev Biol</source>, <volume>325</volume>(<issue>1</issue>), <fpage>138</fpage>-<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2008.10.006</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Leatherbarrow</surname>, <given-names>J. R.</given-names></string-name>, &#x0026; <string-name><surname>Halfon</surname>, <given-names>M. S.</given-names></string-name> (<year>2009</year>). <article-title>Identification of receptor-tyrosine-kinase-signaling target genes reveals receptor-specific activities and pathway branchpoints during Drosophila development</article-title>. <source>Genetics</source>, <volume>181</volume>(<issue>4</issue>), <fpage>1335</fpage>-<lpage>1345</lpage>. doi:<pub-id pub-id-type="doi">10.1534/genetics.108.098475</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Lehmacher</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Abeln</surname>, <given-names>B.</given-names></string-name>, &#x0026; <string-name><surname>Paululat</surname>, <given-names>A.</given-names></string-name> (<year>2012</year>). <article-title>The ultrastructure of Drosophila heart cells</article-title>. <source>Arthropod Struct Dev</source>, <volume>41</volume>(<issue>5</issue>), <fpage>459</fpage>-<lpage>474</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.asd.2012.02.002</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Lin</surname>, <given-names>F. J.</given-names></string-name>, <string-name><surname>You</surname>, <given-names>L. R.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>C. T.</given-names></string-name>, <string-name><surname>Hsu</surname>, <given-names>W. H.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>M. J.</given-names></string-name>, &#x0026; <string-name><surname>Tsai</surname>, <given-names>S. Y.</given-names></string-name> (<year>2012</year>). <article-title>Endocardial cushion morphogenesis and coronary vessel development require chicken ovalbumin upstream promoter-transcription factor II</article-title>. <source>Arterioscler Thromb Vasc Biol</source>, <volume>32</volume>(<issue>11</issue>), <fpage>e135</fpage>-<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1161/ATVBAHA.112.300255</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Qian</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wessells</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Bidet</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Jagla</surname>, <given-names>K.</given-names></string-name>, &#x0026; <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name> (<year>2006</year>). <article-title>Hedgehog and RAS pathways cooperate in the anterior-posterior specification and positioning of cardiac progenitor cells</article-title>. <source>Dev Biol</source>, <volume>290</volume>(<issue>2</issue>), <fpage>373</fpage>-<lpage>385</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2005.11.033</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Lo</surname>, <given-names>P. C.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2001</year>). <article-title>A role for the COUP-TF-related gene seven-up in the diversification of cardioblast identities in the dorsal vessel of Drosophila</article-title>. <source>Mech Dev</source>, <volume>104</volume>(<issue>1-2</issue>), <fpage>49</fpage>-<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">S0925477301003616</pub-id> [pii]</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Lo</surname>, <given-names>P. C.</given-names></string-name>, <string-name><surname>Skeath</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Gajewski</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Schulz</surname>, <given-names>R. A.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2002</year>). <article-title>Homeotic genes autonomously specify the anteroposterior subdivision of the Drosophila dorsal vessel into aorta and heart</article-title>. <source>Dev Biol</source>, <volume>251</volume>(<issue>2</issue>), <fpage>307</fpage>-<lpage>319</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Lovato</surname>, <given-names>T. L.</given-names></string-name>, &#x0026; <string-name><surname>Cripps</surname>, <given-names>R. M.</given-names></string-name> (<year>2016</year>). <article-title>Regulatory Networks that Direct the Development of Specialized Cell Types in the Drosophila Heart</article-title>. <source>J Cardiovasc Dev Dis</source>, <volume>3</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.3390/jcdd3020018</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Lovato</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>T. P.</given-names></string-name>, <string-name><surname>Molina</surname>, <given-names>M. R.</given-names></string-name>, &#x0026; <string-name><surname>Cripps</surname>, <given-names>R. M.</given-names></string-name> (<year>2002</year>). <article-title>The Hox gene abdominal-A specifies heart cell fate in the Drosophila dorsal vessel</article-title>. <source>Development</source>, <volume>129</volume>(<issue>21</issue>), <fpage>5019</fpage>-<lpage>5027</lpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Mandal</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Banerjee</surname>, <given-names>U.</given-names></string-name>, &#x0026; <string-name><surname>Hartenstein</surname>, <given-names>V.</given-names></string-name> (<year>2004</year>). <article-title>Evidence for a fruit fly hemangioblast and similarities between lymph-gland hematopoiesis in fruit fly and mammal aorta-gonadal-mesonephros mesoderm</article-title>. <source>Nat Genet</source>, <volume>36</volume>(<issue>9</issue>), <fpage>1019</fpage>-<lpage>1023</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1404</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Michelson</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Gisselbrecht</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Baek</surname>, <given-names>K. H.</given-names></string-name>, &#x0026; <string-name><surname>Buff</surname>, <given-names>E. M.</given-names></string-name> (<year>1998</year>). <article-title>Dual functions of the heartless fibroblast growth factor receptor in development of the Drosophila embryonic mesoderm</article-title>. <source>Dev Genet</source>, <volume>22</volume>(<issue>3</issue>), <fpage>212</fpage>-<lpage>229</lpage>. doi:<pub-id pub-id-type="doi">10.1002/(SICI)1520-6408</pub-id>(1998)22:3&#x003C;212::AID-DVG4&#x003E;3.0.CO;2-9</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Miquerol</surname>, <given-names>L.</given-names></string-name>, &#x0026; <string-name><surname>Kelly</surname>, <given-names>R. G.</given-names></string-name> (<year>2013</year>). <article-title>Organogenesis of the vertebrate heart</article-title>. <source>Wiley Interdiscip Rev Dev Biol</source>, <volume>2</volume>(<issue>1</issue>), <fpage>17</fpage>-<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1002/wdev.68</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Miskolczi-McCallum</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Scavetta</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Svendsen</surname>, <given-names>P. C.</given-names></string-name>, <string-name><surname>Soanes</surname>, <given-names>K. H.</given-names></string-name>, &#x0026; <string-name><surname>Brook</surname>, <given-names>W. J.</given-names></string-name> (<year>2005</year>). <article-title>The Drosophila melanogaster T-box genes midline and H15 are conserved regulators of heart development</article-title>. <source>Dev Biol</source>, <volume>278</volume>(<issue>2</issue>), <fpage>459</fpage>-<lpage>472</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2004.11.026</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Monier</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Tevy</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Perrin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Capovilla</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Semeriva</surname>, <given-names>M.</given-names></string-name> (<year>2007</year>). <article-title>Downstream of homeotic genes: in the heart of Hox function</article-title>. <source>Fly (Austin)</source>, <volume>1</volume>(<issue>2</issue>), <fpage>59</fpage>-<lpage>67</lpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>Muha</surname>, <given-names>V.</given-names></string-name>, &#x0026; <string-name><surname>M&#x00FC;ller</surname>, <given-names>H. A.</given-names></string-name> (<year>2013</year>). <article-title>Functions and Mechanisms of Fibroblast Growth Factor (FGF) Signalling in Drosophila melanogaster</article-title>. <source>Int J Mol Sci</source>, <volume>14</volume>(<issue>3</issue>), <fpage>5920</fpage>-<lpage>5937</lpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms14035920</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>N&#x00FC;sslein-Volhard</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wieschaus</surname>, <given-names>E.</given-names></string-name>, &#x0026; <string-name><surname>Kluding</surname>, <given-names>H.</given-names></string-name> (<year>1984</year>). <article-title>Mutations affecting the pattern of the larval cuticle inDrosophila melanogaster : I. Zygotic loci on the second chromosome</article-title>. <source>Rouxs Archives of Developmental Biology</source>, <volume>193</volume>(<issue>5</issue>), <fpage>267</fpage>-<lpage>282</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF00848156</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><string-name><surname>O&#x0027;Neill</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Tjian</surname>, <given-names>R.</given-names></string-name>, &#x0026; <string-name><surname>Rubin</surname>, <given-names>G. M.</given-names></string-name> (<year>1994</year>). <article-title>The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway</article-title>. <source>Cell</source>, <volume>78</volume>(<issue>1</issue>), <fpage>137</fpage>-<lpage>147</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>Ponzielli</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Astier</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chartier</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gallet</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Therond</surname>, <given-names>P.</given-names></string-name>, &#x0026; <string-name><surname>Semeriva</surname>, <given-names>M.</given-names></string-name> (<year>2002</year>). <article-title>Heart tube patterning in Drosophila requires integration of axial and segmental information provided by the Bithorax Complex genes and hedgehog signaling</article-title>. <source>Development</source>, <volume>129</volume>(<issue>19</issue>), <fpage>4509</fpage>-<lpage>4521</lpage>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Pradhan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>X. I.</given-names></string-name>, <string-name><surname>Sidhwani</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Marques</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Targoff</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Chi</surname>, <given-names>N. C.</given-names></string-name>, &#x0026; <string-name><surname>Yelon</surname>, <given-names>D.</given-names></string-name> (<year>2017</year>). <article-title>FGF signaling enforces cardiac chamber identity in the developing ventricle</article-title>. <source>Development</source>, <volume>144</volume>(<issue>7</issue>), <fpage>1328</fpage>-<lpage>1338</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.143719</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Qian</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, &#x0026; <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name> (<year>2005</year>). <article-title>Neuromancer Tbx20-related genes (H15/midline) promote cell fate specification and morphogenesis of the Drosophila heart</article-title>. <source>Dev Biol</source>, <volume>279</volume>(<issue>2</issue>), <fpage>509</fpage>-<lpage>524</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2005.01.013</pub-id></mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Qiao</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Harada</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Whitelegge</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Courey</surname>, <given-names>A. J.</given-names></string-name>, &#x0026; <string-name><surname>Bowie</surname>, <given-names>J. U.</given-names></string-name> (<year>2006</year>). <article-title>Mae inhibits Pointed-P2 transcriptional activity by blocking its MAPK docking site</article-title>. <source>Embo J</source>, <volume>25</volume>(<issue>1</issue>), <fpage>70</fpage>-<lpage>79</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.emboj.7600924</pub-id></mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Qiao</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Sawaya</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Hunter</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Gingery</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Courey</surname>, <given-names>A. J.</given-names></string-name>, &#x0026; <string-name><surname>Bowie</surname>, <given-names>J. U.</given-names></string-name> (<year>2004</year>). <article-title>Derepression by depolymerization; structural insights into the regulation of Yan by Mae</article-title>. <source>Cell</source>, <volume>118</volume>(<issue>2</issue>), <fpage>163</fpage>-<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2004.07.010</pub-id></mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><string-name><surname>Rana</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Christoffels</surname>, <given-names>V. M.</given-names></string-name>, &#x0026; <string-name><surname>Moorman</surname>, <given-names>A. F.</given-names></string-name> (<year>2013</year>). <article-title>A molecular and genetic outline of cardiac morphogenesis</article-title>. <source>Acta Physiol (Oxf)</source>, <volume>207</volume>(<issue>4</issue>), <fpage>588</fpage>-<lpage>615</lpage>. doi:<pub-id pub-id-type="doi">10.1111/apha.12061</pub-id></mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name>, &#x0026; <string-name><surname>Rubin</surname>, <given-names>G. M.</given-names></string-name> (<year>1995</year>). <article-title>Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway</article-title>. <source>Cell</source>, <volume>81</volume>(<issue>6</issue>), <fpage>857</fpage>-<lpage>866</lpage>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>The Dorsocross T-box genes are key components of the regulatory network controlling early cardiogenesis in Drosophila</article-title>. <source>Development</source>, <volume>132</volume>(<issue>22</issue>), <fpage>4911</fpage>-<lpage>4925</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.02077</pub-id></mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2010</year>). <article-title>Genetic and genomic dissection of cardiogenesis in the Drosophila model</article-title>. <source>Pediatr Cardiol</source>, <volume>31</volume>(<issue>3</issue>), <fpage>325</fpage>-<lpage>334</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00246-009-9612-1</pub-id></mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Schaub</surname>, <given-names>C.</given-names></string-name> (<year>2017</year>). <article-title>T-Box Genes in Drosophila Mesoderm Development</article-title>. <source>Curr Top Dev Biol</source>, <volume>122</volume>, <fpage>161</fpage>-<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1016/bs.ctdb.2016.06.003</pub-id></mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hollfelder</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ismat</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2012</year>). <article-title>The FGF8-related signals Pyramus and Thisbe promote pathfinding, substrate adhesion, and survival of migrating longitudinal gut muscle founder cells</article-title>. <source>Dev Biol</source>, <volume>368</volume>(<issue>1</issue>), <fpage>28</fpage>-<lpage>43</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2012.05.010</pub-id></mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H. H.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2003</year>). <article-title>The T-box-encoding Dorsocross genes function in amnioserosa development and the patterning of the dorsolateral germ band downstream of Dpp</article-title>. <source>Development</source>, <volume>130</volume>(<issue>14</issue>), <fpage>3187</fpage>-<lpage>3204</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.00548</pub-id></mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Mohler</surname>, <given-names>J. P.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>Tbx20-related genes, mid and H15, are required for tinman expression, proper patterning, and normal differentiation of cardioblasts in Drosophila</article-title>. <source>Mech Dev</source>, <volume>122</volume>(<issue>9</issue>), <fpage>1056</fpage>-<lpage>1069</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mod.2005.04.006</pub-id></mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><string-name><surname>Rogge</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Green</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Urano</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Horn-Saban</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mlodzik</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Shilo</surname>, <given-names>B. Z.</given-names></string-name>, <string-name><surname>Hartenstein</surname>, <given-names>V.</given-names></string-name>, &#x0026; <string-name><surname>Banerjee</surname>, <given-names>U.</given-names></string-name> (<year>1995</year>). <article-title>The role of yan in mediating the choice between cell division and differentiation</article-title>. <source>Development</source>, <volume>121</volume>(<issue>12</issue>), <fpage>3947</fpage>-<lpage>3958</lpage>.</mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><string-name><surname>Ryan</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Hendren</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Helander</surname>, <given-names>L. A.</given-names></string-name>, &#x0026; <string-name><surname>Cripps</surname>, <given-names>R. M.</given-names></string-name> (<year>2007</year>). <article-title>The NK homeodomain transcription factor Tinman is a direct activator of seven-up in the Drosophila dorsal vessel</article-title>. <source>Dev Biol</source>, <volume>302</volume>(<issue>2</issue>), <fpage>694</fpage>-<lpage>702</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2006.10.025</pub-id></mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><string-name><surname>Ryan</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Hoshizaki</surname>, <given-names>D. K.</given-names></string-name>, &#x0026; <string-name><surname>Cripps</surname>, <given-names>R. M.</given-names></string-name> (<year>2005</year>). <article-title>Homeotic selector genes control the patterning of seven-up expressing cells in the Drosophila dorsal vessel</article-title>. <source>Mech Dev</source>, <volume>122</volume>(<issue>9</issue>), <fpage>1023</fpage>-<lpage>1033</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mod.2005.04.007</pub-id></mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><string-name><surname>Ryu</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Najand</surname>, <given-names>N.</given-names></string-name>, &#x0026; <string-name><surname>Brook</surname>, <given-names>W. J.</given-names></string-name> (<year>2011</year>). <article-title>Tinman is a direct activator of midline in the Drosophila dorsal vessel</article-title>. <source>Dev Dyn</source>, <volume>240</volume>(<issue>1</issue>), <fpage>86</fpage>-<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.1002/dvdy.22495</pub-id></mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><string-name><surname>Salzberg</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>D&#x0027;Evelyn</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Schulze</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Strumpf</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>L.</given-names></string-name>, &#x0026; <string-name><surname>Bellen</surname>, <given-names>H. J.</given-names></string-name> (<year>1994</year>). <article-title>Mutations affecting the pattern of the PNS in Drosophila reveal novel aspects of neuronal development</article-title>. <source>Neuron</source>, <volume>13</volume>(<issue>2</issue>), <fpage>269</fpage>-<lpage>287</lpage>.</mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><string-name><surname>Scholz</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Deatrick</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Klaes</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Kl&#x00E4;mbt</surname>, <given-names>C.</given-names></string-name> (<year>1993</year>). <article-title>Genetic dissection of pointed, a Drosophila gene encoding two ETS-related proteins</article-title>. <source>Genetics</source>, <volume>135</volume>(<issue>2</issue>), <fpage>455</fpage>-<lpage>468</lpage>.</mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><string-name><surname>Shilo</surname>, <given-names>B. Z.</given-names></string-name> (<year>2014</year>). <article-title>The regulation and functions of MAPK pathways in Drosophila</article-title>. <source>Methods</source>, <volume>68</volume>(<issue>1</issue>), <fpage>151</fpage>-<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ymeth.2014.01.020</pub-id></mixed-citation></ref>
<ref id="c90"><mixed-citation publication-type="journal"><string-name><surname>Shwartz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yogev</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schejter</surname>, <given-names>E. D.</given-names></string-name>, &#x0026; <string-name><surname>Shilo</surname>, <given-names>B. Z.</given-names></string-name> (<year>2013</year>). <article-title>Sequential activation of ETS proteins provides a sustained transcriptional response to EGFR signaling</article-title>. <source>Development</source>, <volume>140</volume>(<issue>13</issue>), <fpage>2746</fpage>-<lpage>2754</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.093138</pub-id></mixed-citation></ref>
<ref id="c91"><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>, <given-names>M. K.</given-names></string-name>, <string-name><surname>Christoffels</surname>, <given-names>V. M.</given-names></string-name>, <string-name><surname>Dias</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Trowe</surname>, <given-names>M. O.</given-names></string-name>, <string-name><surname>Petry</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schuster-Gossler</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Burger</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ericson</surname>, <given-names>J.</given-names></string-name>, &#x0026; <string-name><surname>Kispert</surname>, <given-names>A.</given-names></string-name> (<year>2005</year>). <article-title>Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2</article-title>. <source>Development</source>, <volume>132</volume>(<issue>12</issue>), <fpage>2697</fpage>-<lpage>2707</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.01854</pub-id></mixed-citation></ref>
<ref id="c92"><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hoogaars</surname>, <given-names>W. M.</given-names></string-name>, <string-name><surname>Barnett</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Grieskamp</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Rana</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Buermans</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Farin</surname>, <given-names>H. F.</given-names></string-name>, <string-name><surname>Petry</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Heallen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Moorman</surname>, <given-names>A. F.</given-names></string-name>, <string-name><surname>t Hoen</surname>, <given-names>P. A.</given-names></string-name>, <string-name><surname>Kispert</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Christoffels</surname>, <given-names>V. M.</given-names></string-name> (<year>2012</year>). <article-title>Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation</article-title>. <source>Cell Mol Life Sci</source>, <volume>69</volume>(<issue>8</issue>), <fpage>1377</fpage>-<lpage>1389</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00018-011-0884-2</pub-id></mixed-citation></ref>
<ref id="c93"><mixed-citation publication-type="journal"><string-name><surname>Steimle</surname>, <given-names>J. D.</given-names></string-name>, &#x0026; <string-name><surname>Moskowitz</surname>, <given-names>I. P.</given-names></string-name> (<year>2017</year>). <article-title>TBX5: A Key Regulator of Heart Development</article-title>. <source>Curr Top Dev Biol</source>, <volume>122</volume>, <fpage>195</fpage>-<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1016/bs.ctdb.2016.08.008</pub-id></mixed-citation></ref>
<ref id="c94"><mixed-citation publication-type="journal"><string-name><surname>Stennard</surname>, <given-names>F. A.</given-names></string-name>, <string-name><surname>Costa</surname>, <given-names>M. W.</given-names></string-name>, <string-name><surname>Elliott</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Rankin</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Haast</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Lai</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>McDonald</surname>, <given-names>L. P.</given-names></string-name>, <string-name><surname>Niederreither</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Dolle</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Bruneau</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Zorn</surname>, <given-names>A. M.</given-names></string-name>, &#x0026; <string-name><surname>Harvey</surname>, <given-names>R. P.</given-names></string-name> (<year>2003</year>). <article-title>Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart</article-title>. <source>Dev Biol</source>, <volume>262</volume>(<issue>2</issue>), <fpage>206</fpage>-<lpage>224</lpage>.</mixed-citation></ref>
<ref id="c95"><mixed-citation publication-type="journal"><string-name><surname>Stennard</surname>, <given-names>F. A.</given-names></string-name>, <string-name><surname>Costa</surname>, <given-names>M. W.</given-names></string-name>, <string-name><surname>Lai</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Biben</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Furtado</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Solloway</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>McCulley</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Leimena</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Preis</surname>, <given-names>J. I.</given-names></string-name>, <string-name><surname>Dunwoodie</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Elliott</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Prall</surname>, <given-names>O. W.</given-names></string-name>, <string-name><surname>Black</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>Fatkin</surname>, <given-names>D.</given-names></string-name>, &#x0026; <string-name><surname>Harvey</surname>, <given-names>R. P.</given-names></string-name> (<year>2005</year>). <article-title>Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation</article-title>. <source>Development</source>, <volume>132</volume>(<issue>10</issue>), <fpage>2451</fpage>-<lpage>2462</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.01799</pub-id></mixed-citation></ref>
<ref id="c96"><mixed-citation publication-type="journal"><string-name><surname>Su</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Fujioka</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Goto</surname>, <given-names>T.</given-names></string-name>, &#x0026; <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name> (<year>1999</year>). <article-title>The Drosophila homeobox genes zfh-1 and even-skipped are required for cardiac-specific differentiation of a numb-dependent lineage decision</article-title>. <source>Development</source>, <volume>126</volume>(<issue>14</issue>), <fpage>3241</fpage>-<lpage>3251</lpage>.</mixed-citation></ref>
<ref id="c97"><mixed-citation publication-type="journal"><string-name><surname>Takeuchi</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Mileikovskaia</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Koshiba-Takeuchi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Heidt</surname>, <given-names>A. B.</given-names></string-name>, <string-name><surname>Mori</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Arruda</surname>, <given-names>E. P.</given-names></string-name>, <string-name><surname>Gertsenstein</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Georges</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Davidson</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Mo</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hui</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>Henkelman</surname>, <given-names>R. M.</given-names></string-name>, <string-name><surname>Nemer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Black</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>Nagy</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Bruneau</surname>, <given-names>B. G.</given-names></string-name> (<year>2005</year>). <article-title>Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development</article-title>. <source>Development</source>, <volume>132</volume>(<issue>10</issue>), <fpage>2463</fpage>-<lpage>2474</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.01827</pub-id></mixed-citation></ref>
<ref id="c98"><mixed-citation publication-type="journal"><string-name><surname>Tootle</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>P. S.</given-names></string-name>, &#x0026; <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name> (<year>2003</year>). <article-title>CRM1-mediated nuclear export and regulated activity of the Receptor Tyrosine Kinase antagonist YAN require specific interactions with MAE</article-title>. <source>Development</source>, <volume>130</volume>(<issue>5</issue>), <fpage>845</fpage>-<lpage>857</lpage>.</mixed-citation></ref>
<ref id="c99"><mixed-citation publication-type="journal"><string-name><surname>T&#x00F6;r&#x00F6;k</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tick</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Alvarado</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Kiss</surname>, <given-names>I.</given-names></string-name> (<year>1993</year>). <article-title>P-lacW insertional mutagenesis on the second chromosome of Drosophila melanogaster: isolation of lethals with different overgrowth phenotypes</article-title>. <source>Genetics</source>, <volume>135</volume>(<issue>1</issue>), <fpage>71</fpage>-<lpage>80</lpage>.</mixed-citation></ref>
<ref id="c100"><mixed-citation publication-type="journal"><string-name><surname>Venken</surname>, <given-names>K. J.</given-names></string-name>, <string-name><surname>Schulze</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Haelterman</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Evans-Holm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Carlson</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Levis</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Spradling</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Hoskins</surname>, <given-names>R. A.</given-names></string-name>, &#x0026; <string-name><surname>Bellen</surname>, <given-names>H. J.</given-names></string-name> (<year>2011</year>). <article-title>MiMIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes</article-title>. <source>Nat Methods</source>, <volume>8</volume>(<issue>9</issue>), <fpage>737</fpage>-<lpage>743</lpage>.</mixed-citation></ref>
<ref id="c101"><mixed-citation publication-type="journal"><string-name><surname>Vivekanand</surname>, <given-names>P.</given-names></string-name>, &#x0026; <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name> (<year>2012</year>). <article-title>The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2</article-title>. <source>PLoS One</source>, <volume>7</volume>(<issue>5</issue>), <fpage>e37151</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0037151</pub-id></mixed-citation></ref>
<ref id="c102"><mixed-citation publication-type="journal"><string-name><surname>Vivekanand</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Tootle</surname>, <given-names>T. L.</given-names></string-name>, &#x0026; <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name> (<year>2004</year>). <article-title>MAE, a dual regulator of the EGFR signaling pathway, is a target of the Ets transcription factors PNT and YAN</article-title>. <source>Mech Dev</source>, <volume>121</volume>(<issue>12</issue>), <fpage>1469</fpage>-<lpage>1479</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mod.2004.07.009</pub-id></mixed-citation></ref>
<ref id="c103"><mixed-citation publication-type="journal"><string-name><surname>Ward</surname>, <given-names>E. J.</given-names></string-name>, &#x0026; <string-name><surname>Skeath</surname>, <given-names>J. B.</given-names></string-name> (<year>2000</year>). <article-title>Characterization of a novel subset of cardiac cells and their progenitors in the Drosophila embryo</article-title>. <source>Development</source>, <volume>127</volume>(<issue>22</issue>), <fpage>4959</fpage>-<lpage>4969</lpage>.</mixed-citation></ref>
<ref id="c104"><mixed-citation publication-type="journal"><string-name><surname>Webber</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mitchell-Dick</surname>, <given-names>A.</given-names></string-name>, &#x0026; <string-name><surname>Rebay</surname>, <given-names>I.</given-names></string-name> (<year>2013</year>). <article-title>3D chromatin interactions organize Yan chromatin occupancy and repression at the even-skipped locus</article-title>. <source>Genes Dev</source>, <volume>27</volume>(<issue>21</issue>), <fpage>2293</fpage>-<lpage>2298</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.225789.113</pub-id></mixed-citation></ref>
<ref id="c105"><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Lanz</surname>, <given-names>R. B.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Respress</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Ather</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Wehrens</surname>, <given-names>X. H.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>M. J.</given-names></string-name>, &#x0026; <string-name><surname>Tsai</surname>, <given-names>S. Y.</given-names></string-name> (<year>2013</year>). <article-title>Atrial identity is determined by a COUP-TFII regulatory network</article-title>. <source>Dev Cell</source>, <volume>25</volume>(<issue>4</issue>), <fpage>417</fpage>-<lpage>426</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.devcel.2013.04.017</pub-id></mixed-citation></ref>
<ref id="c106"><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>C. T.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>S. Y.</given-names></string-name>, &#x0026; <string-name><surname>Tsai</surname>, <given-names>M. J.</given-names></string-name> (<year>2016</year>). <article-title>Choose your destiny: Make a cell fate decision with COUP-TFII</article-title>. <source>J Steroid Biochem Mol Biol</source>, <volume>157</volume>, <fpage>7</fpage>-<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsbmb.2015.11.011</pub-id></mixed-citation></ref>
<ref id="c107"><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Golden</surname>, <given-names>K.</given-names></string-name>, &#x0026; <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name> (<year>1995</year>). <article-title>Heart development in Drosophila requires the segment polarity gene wingless</article-title>. <source>Dev Biol</source>, <volume>169</volume>(<issue>2</issue>), <fpage>619</fpage>-<lpage>628</lpage>. doi:<pub-id pub-id-type="doi">10.1006/dbio.1995.1174</pub-id></mixed-citation></ref>
<ref id="c108"><mixed-citation publication-type="journal"><string-name><surname>Yamada</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Okabe</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Hiromi</surname>, <given-names>Y.</given-names></string-name> (<year>2003</year>). <article-title>EDL/MAE regulates EGF-mediated induction by antagonizing Ets transcription factor Pointed</article-title>. <source>Development</source>, <volume>130</volume>(<issue>17</issue>), <fpage>4085</fpage>-<lpage>4096</lpage>.</mixed-citation></ref>
<ref id="c109"><mixed-citation publication-type="journal"><string-name><surname>Yin</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>X. L.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>1997</year>). <article-title>Regulation of the twist target gene tinman by modular cis-regulatory elements during early mesoderm development</article-title>. <source>Development</source>, <volume>124</volume>(<issue>24</issue>), <fpage>4971</fpage>-<lpage>4982</lpage>.</mixed-citation></ref>
<ref id="c110"><mixed-citation publication-type="journal"><string-name><surname>Zaffran</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Reim</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Qian</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lo</surname>, <given-names>P. C.</given-names></string-name>, <string-name><surname>Bodmer</surname>, <given-names>R.</given-names></string-name>, &#x0026; <string-name><surname>Frasch</surname>, <given-names>M.</given-names></string-name> (<year>2006</year>). <article-title>Cardioblast-intrinsic Tinman activity controls proper diversification and differentiation of myocardial cells in Drosophila</article-title>. <source>Development</source>, <volume>133</volume>(<issue>20</issue>), <fpage>4073</fpage>-<lpage>4083</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.02586</pub-id></mixed-citation></ref>
<ref id="c111"><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Schnitzler</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Agapite</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Steller</surname>, <given-names>H.</given-names></string-name>, &#x0026; <string-name><surname>Nambu</surname>, <given-names>J. R.</given-names></string-name> (<year>1997</year>). <article-title>Cooperative functions of the reaper and head involution defective genes in the programmed cell death of Drosophila central nervous system midline cells</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>94</volume>(<issue>10</issue>), <fpage>5131</fpage>-<lpage>5136</lpage>.</mixed-citation></ref>
</ref-list>
<sec id="s8" sec-type="supplementary-material">
<title>Supplementary information</title>
<table-wrap id="tblS1" orientation="portrait" position="float">
<label>Supplementary Table 1.</label>
<caption><title>Alleles with cardioblast patterning defects isolated and/or characterized in this study.</title>
<p>Unless indicated otherwise nucleotide positions are relative to transcription start site of transcript RA and amino acid positions of protein isoform PA (FB2017_01, released February 14, 2017; D. melanogaster R6.14); &#x002A; indicates a nonsense mutation, n.d.: not determined.</p></caption>
<graphic xlink:href="217679_tblS1.tif"/>
</table-wrap>
<table-wrap id="tblS2" orientation="portrait" position="float">
<label>Supplementary Table 2.</label>
<caption><title>Characterization of <italic>edl</italic> deletions via PCR.</title>
<p>Presence (&#x002B;) or absence (-) of DNA fragments after PCR reaction including genomic DNA from homozygous <italic>S-18a-13b-16c.1</italic> control (<italic>WT</italic>), <italic>Df(2R)edl-S0520</italic> or <italic>edl</italic><sup><italic>k06602</italic></sup> animals and primer pairs as indicated. CDS: part of coding sequence, TSS: transcription start site, n.d.: not determined. Amplicons are listed in linear order as located on chromosome 2R. &#x002A; Six additional intronic <italic>GEFmeso</italic> amplicons were also negative in <italic>S0520</italic>.</p></caption>
<graphic xlink:href="217679_tblS2.tif"/>
</table-wrap>
<p><bold>Figure 1 - source data 1. Quantification of Doc<sup>&#x002B;</sup> oCBs, Doc<sup>&#x2212;</sup> gCBs and total cardioblasts.</bold> data file: fig1-data1.xlsx</p>
<fig id="figS1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1 - Figure supplement 1.</label>
<caption><title>Cardiac patterning phenotypes in additional alleles of FGF and EGF pathway mutants.</title>
<p>Embryos stained for H15 and Doc as in <xref ref-type="fig" rid="fig1">Figure 1</xref>. (A) Wild type with normal CB pattern. Reduced FGF/Htl signaling in <italic>pyr<sup>18</sup>/Df(2R)BSC25</italic> (<italic>pyr</italic><sup><italic>-/-</italic></sup> <italic>ths</italic><sup><italic>&#x002B;/-</italic></sup>) embryos (B) or homozygous mutants with the hypomorphic allele <italic>htl</italic><sup><italic>YY262</italic></sup> (C) leads to a random loss of gCBs and oCBs. (D) Neither significant changes in CB number nor patterning defects were observed in homozygous <italic>ths</italic><sup><italic>759</italic></sup> mutants. The mutants <italic>Egfr</italic><sup><italic>f2</italic></sup> (E) and <italic>spi</italic><sup><italic>1</italic></sup> (F) show essentially the same phenotypes as the corresponding alleles of the same genes shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></caption>
<graphic xlink:href="217679_figS1.tif"/>
</fig>
<fig id="figS2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1 - Figure supplement 2.</label>
<caption><title>Extended analysis of cardiac patterning in EGF pathway mutants.</title>
<p>Expression of Tin and H15 detected by immunostaining in stage 16 embryos. (A) In the wild type, each abdominal hemisegment contains four Tin<sup>&#x002B;</sup>H15<sup>&#x002B;</sup> gCBs (white, arrowheads) and several Tin<sup>&#x002B;</sup>H15<sup>-</sup> PCs. In the anterior aorta (bracket) all CBs express Tin. (B) Homozygous <italic>spi</italic><sup><italic>1</italic></sup> mutant with reduced number of gCBs. (C) Homozygous <italic>S</italic><sup><italic>B0453</italic></sup> mutant in which only one pair of Tin<sup>&#x002B;</sup> gCBs has developed in abdominal segments. CBs of the anterior aorta (aa) are less affected. Correlating with the presence of Doc<sup>&#x002B;</sup> CBs, Tin<sup>-</sup> CBs are present at near wild type numbers in <italic>spi</italic> and <italic>S</italic> mutants.</p></caption>
<graphic xlink:href="217679_figS2.tif"/>
</fig>
<fig id="figS3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1 - Figure supplement 3.</label>
<caption><title>Analysis of apoptosis in <italic>Star</italic> mutants.</title>
<p>TUNEL assay co-stained for Tin to detect apoptotic cells in the cardiogenic mesoderm of wild type embryos (A,C,E) and in amorphic <italic>S</italic> mutants (B,D,F) at the indicated stages. TUNEL signals are not found within in the Tin<sup>&#x002B;</sup> cardiogenic mesoderm of stage 10, 11 and 12 embryos in both wild type and mutant embryos, although such signals could readily detected in more ventral and lateral regions as well as in the head (arrows). Note the higher abundance of TUNEL staining in Tin-negative tissues in the mutants. This suggests that EGF signaling does not serve as a mere survival cue in the cardiogenic mesoderm but has a major function in specifying cardiac fates.</p></caption>
<graphic xlink:href="217679_figS3.tif"/>
</fig>
<fig id="figS4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1 - Figure supplement 4.</label>
<caption><title>Expression of <italic>rho</italic> in cardiac cells.</title>
<p>Detection of <italic>rho</italic> mRNA (green), Mef2 (blue) and Doc (red). (A) At stage 11, <italic>rho</italic> is detectable in clusters C14/C16 of the cardiac mesoderm and is fading from the central Doc-negative region containing EPC and somatic muscle progenitors. Some cardiac cells express higher levels than others. (B) At late stage 11, <italic>rho</italic> is expressed at high levels in one or a few cardiac progenitors close to the dorsal segment borders. (C, D) As cardioblasts align near the dorsal mesoderm margin during stage 12, <italic>rho</italic> continues to be expressed in most CBs.</p></caption>
<graphic xlink:href="217679_figS4.tif"/>
</fig>
<fig id="figS5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3 - Figure supplement 1.</label>
<caption><title>Cardiac <italic>edl</italic> expression.</title>
<p>Detection of <italic>edl</italic> RNA in wild type embryos co-stained against Mef2 (A,C,D; lateral views) or Doc (B; dorsal view). (A) Stage 10 embryo showing strong <italic>edl</italic> expression in numerous ectodermal and mesodermal tissues including the Mef2-positive areas of the early cardiogenic mesoderm (CM) and parts of the somatic mesoderm (SM). (B) Stage 11 embryo in which <italic>edl</italic> RNA is strongly expressed in Doc<sup>&#x002B;</sup> cardiogenic clusters. High expression is also seen in the band of trunk visceral mesoderm founders, but not in adjacent migrating longitudinal visceral muscle founders (also Doc<sup>&#x002B;</sup>). (C) Cardiac <italic>edl</italic> expression persists during germ band retraction. (D) Thereafter, it fades in the cardioblasts but continues to be expressed in the pericardial region.</p></caption>
<graphic xlink:href="217679_figS5.tif"/>
</fig>
<p><bold>Figure 4 - source data 1. Quantification of cardioblasts in various genotypes affecting Edl, Pnt or Yan/Aop activities.</bold> data file: fig4-data1.xlsx</p>
<fig id="figS6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5 - Figure supplement 1.</label>
<caption><title>Epistatic relationship between <italic>edl</italic> and <italic>svp</italic>.</title>
<p>Embryos stained for H15 and Doc as the wild-type control in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. (A) Loss of <italic>Doc</italic> expression in homozygous <italic>svp</italic><sup><italic>AE127</italic></sup> mutants. (B) All CBs remain Doc-negative upon pan-mesodermal <italic>edl</italic> overexpression in the <italic>svp</italic><sup><italic>AE127</italic></sup> mutant background. (C) Overexpression of <italic>svp</italic> in CBs leads to ectopic <italic>Doc</italic> expression. Sporadic reduction in H15 expression (green CBs) may result from repression of <italic>tin</italic>, since similar H15 reductions were observed in CB-specific <italic>tin</italic>-mutants (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). (D) In the absence of <italic>edl</italic>, forced expression of <italic>svp</italic> with the same driver also expands the population of Doc<sup>&#x002B;</sup> CBs. This suggests that <italic>svp</italic> is epistatic to <italic>edl</italic> during of CB patterning.</p></caption>
<graphic xlink:href="217679_figS6.tif"/>
</fig>
<fig id="figS7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6 - Figure supplement 1.</label>
<caption><title>Additional data supporting <italic>mid</italic> function in gCBs.</title>
<p>Stainings with antibodies against Svp (green), Doc2&#x002B;3 (red) and Tin (blue). Shown are representative regions of the developing heart in stage 15-16 embryos (merged and single channels as indicated). (A) Control embryo showing co-expression of Svp and Doc in the Tin-negative oCBs (arrows). (B) In amorphic <italic>pnt</italic> mutants (this example: <italic>pnt</italic><sup><italic>&#x0394;88</italic></sup>/<italic>Df(3R)Exel9012</italic>) expression of Svp expands simultaneously with Doc. (C) Overexpressing <italic>mid</italic> in a <italic>pnt</italic> null background in the dorsal mesoderm via <italic>tinD</italic>-GAL4 largely reverts the expansion of both Doc and Svp. (D) By contrast, overexpressing <italic>tin</italic> with the same driver in <italic>pnt</italic> mutants has a repressive effect on Doc but not Svp expression (arrowheads).</p></caption>
<graphic xlink:href="217679_figS7.tif"/>
</fig>
<fig id="figS8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - Figure supplement 1.</label>
<caption><title>Further analysis of <italic>midline</italic> regulation.</title>
<p>Stainings for GFP (green), H15 (red) and Tin (blue) in stage 16 embryos carrying the <italic>midE19-GFP</italic> reporter as the control in <xref ref-type="fig" rid="fig7">Figure 7A</xref>. (A) Mesodermal overexpression of <italic>edl</italic> via <italic>how<sup>24B</sup>-</italic>GAL4 leads to a loss of <italic>midE19</italic>-GFP in many gCBs (purple). (B) Loss of <italic>rho</italic> function leads to a complete loss of GFP in some of the retained gCBs (arrowheads) and a level reduction in others (arrows). In comparison to <italic>pnt</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), a higher fraction of gCBs retains substantial GFP expression indicating additional, <italic>rho-</italic>independent inputs upstream of Pnt.</p></caption>
<graphic xlink:href="217679_figS8.tif"/>
</fig>
</sec>
</back>
</article>